<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7764432</article-id><article-id pub-id-type="pmid">33322162</article-id><article-id pub-id-type="doi">10.3390/molecules25245905</article-id><article-id pub-id-type="publisher-id">molecules-25-05905</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sikander</surname><given-names>Mohammed</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05905">1</xref><xref ref-type="aff" rid="af2-molecules-25-05905">2</xref><xref ref-type="author-notes" rid="fn1-molecules-25-05905">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Malik</surname><given-names>Shabnam</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05905">1</xref><xref ref-type="aff" rid="af2-molecules-25-05905">2</xref><xref ref-type="author-notes" rid="fn1-molecules-25-05905">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Rodriguez</surname><given-names>Anyssa</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05905">1</xref><xref ref-type="aff" rid="af2-molecules-25-05905">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0073-8828</contrib-id><name><surname>Yallapu</surname><given-names>Murali M.</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05905">1</xref><xref ref-type="aff" rid="af2-molecules-25-05905">2</xref></contrib><contrib contrib-type="author"><name><surname>Narula</surname><given-names>Acharan S.</given-names></name><xref ref-type="aff" rid="af3-molecules-25-05905">3</xref></contrib><contrib contrib-type="author"><name><surname>Satapathy</surname><given-names>Sanjaya K.</given-names></name><xref ref-type="aff" rid="af4-molecules-25-05905">4</xref></contrib><contrib contrib-type="author"><name><surname>Dhevan</surname><given-names>Vijian</given-names></name><xref ref-type="aff" rid="af5-molecules-25-05905">5</xref></contrib><contrib contrib-type="author"><name><surname>Chauhan</surname><given-names>Subhash C.</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05905">1</xref><xref ref-type="aff" rid="af2-molecules-25-05905">2</xref></contrib><contrib contrib-type="author"><name><surname>Jaggi</surname><given-names>Meena</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05905">1</xref><xref ref-type="aff" rid="af2-molecules-25-05905">2</xref><xref rid="c1-molecules-25-05905" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Carradori</surname><given-names>Simone</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-25-05905"><label>1</label>Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA; <email>mohammed.sikander@utrgv.edu</email> (M.S.); <email>fnu.shabnam@utrgv.edu</email> (S.M.); <email>anyssa.rodriguez01@utrgv.edu</email> (A.R.); <email>murali.yallapu@utrgv.edu</email> (M.M.Y.); <email>subhash.chauhan@utrgv.edu</email> (S.C.C.)</aff><aff id="af2-molecules-25-05905"><label>2</label>South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA</aff><aff id="af3-molecules-25-05905"><label>3</label>Narula Research, LLC, 107 Boulder Bluff, Chapel Hill, NC 27516, USA; <email>anarula1@nc.rr.com</email></aff><aff id="af4-molecules-25-05905"><label>4</label>Division of Hepatology, Department of Internal Medicine, Sandra Atlas Bass Center for Liver Diseases and Transplantation, Barbara and Zucker School of Medicine, Northwell Health, Manhasset, NY 11030, USA; <email>ssatapat@northwell.edu</email></aff><aff id="af5-molecules-25-05905"><label>5</label>Department of Surgery, School of Medicine, University of Texas Rio Grande Valley, Edinburg, TX 78539, USA; <email>vijian.dhevan@utrgv.edu</email></aff><author-notes><corresp id="c1-molecules-25-05905"><label>*</label>Correspondence: <email>meena.jaggi@utrgv.edu</email>; Tel.: +956-296-2008</corresp><fn id="fn1-molecules-25-05905"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>13</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2020</year></pub-date><volume>25</volume><issue>24</issue><elocation-id>5905</elocation-id><history><date date-type="received"><day>02</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>09</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>COVID-19 is known as one of the deadliest pandemics of the century. The rapid spread of this deadly virus at incredible speed has stunned the planet and poses a challenge to global scientific and medical communities. Patients with COVID-19 are at an increased risk of co-morbidities associated with liver dysfunction and injury. Moreover, hepatotoxicity induced by antiviral therapy is gaining importance and is an area of great concern. Currently, alternatives therapies are being sought to mitigate hepatic damage, and there has been growing interest in the research on bioactive phytochemical agents (nutraceuticals) due to their versatility in health benefits reported in various epidemiological studies. Therefore, this review provides information and summarizes the juncture of antiviral, immunomodulatory, and hepatoprotective nutraceuticals that can be useful during the management of COVID-19.</p></abstract><kwd-group><kwd>COVID-19</kwd><kwd>coronavirus</kwd><kwd>ACE2</kwd><kwd>hepatic dysfunctions</kwd><kwd>hepatoprotective agents</kwd><kwd>nutraceuticals</kwd><kwd>SARS-CoV-2</kwd></kwd-group></article-meta></front><body><sec id="sec1-molecules-25-05905"><title>1. COVID-19: From Outbreak to Pandemic</title><p>The Coronavirus Disease 19 (COVID-19) is a highly infectious disease caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) [<xref rid="B1-molecules-25-05905" ref-type="bibr">1</xref>] (<xref ref-type="fig" rid="molecules-25-05905-f001">Figure 1</xref>A). The COVID-19 disease, which has infected millions and shocked the planet, emerges from the animal kingdom. Since December 2019, the first case of coronavirus disease (COVID-19) resulted from zoonotic transmission from the seafood and live wild animal market in Wuhan, China. As of 12 December 2020, approximately 72 million infections and more than 1,610,684 deaths have been reported, and these statistics are likely to be higher due to inadequate monitoring in parts of the world and asymptomatic carriers [<xref rid="B2-molecules-25-05905" ref-type="bibr">2</xref>,<xref rid="B3-molecules-25-05905" ref-type="bibr">3</xref>,<xref rid="B4-molecules-25-05905" ref-type="bibr">4</xref>] (<xref ref-type="fig" rid="molecules-25-05905-f001">Figure 1</xref>B). The SARS-CoV-2 pandemic can be regarded as the largest global public health disaster since the onset of the 1918 pandemic. </p><p>SARS-CoV-2 primarily causes respiratory symptoms, including flu-like symptoms and interstitial pneumonia, which may further progress into fatal Acute Respiratory Distress Syndrome (ARDS) condition [<xref rid="B5-molecules-25-05905" ref-type="bibr">5</xref>,<xref rid="B6-molecules-25-05905" ref-type="bibr">6</xref>]. However, other organs, particularly the liver, heart, and kidneys, are also affected, resulting in multi-organ failure and death in some patients [<xref rid="B6-molecules-25-05905" ref-type="bibr">6</xref>]. Higher incidences of aminotransferases in and/or bilirubin were reported in COVID-19 patients to a varying degree. Moreover, several COVID-19 patients have experienced some type of liver injury, particularly those with serious or critical cases [<xref rid="B7-molecules-25-05905" ref-type="bibr">7</xref>]. This prompted hepatologists to collaborate with other physicians, such as internal medicine and emergency departments, to protect the health status and avoid the adverse effects of COVID-19 in people with liver disease. Given the global burden of chronic liver disease, this pandemic could further worsen the treatment of patients at risk [<xref rid="B8-molecules-25-05905" ref-type="bibr">8</xref>]. This review aims to gather information on medicinal plants and nutraceuticals with hepatoprotective activity, which can protect against the hepatic damage caused by COVID-19 and antiviral drugs. </p></sec><sec id="sec2-molecules-25-05905"><title>2. Pathogenesis of COVID-19</title><p>Coronaviruses are single-stranded RNA viruses known to cause human respiratory tract or animal intestinal infection [<xref rid="B9-molecules-25-05905" ref-type="bibr">9</xref>,<xref rid="B10-molecules-25-05905" ref-type="bibr">10</xref>,<xref rid="B11-molecules-25-05905" ref-type="bibr">11</xref>] (<xref ref-type="fig" rid="molecules-25-05905-f002">Figure 2</xref>A). Primarily, there are four main types, including &#x003b1;-coronavirus, &#x003b2;-coronavirus, &#x003b4;-coronavirus, and &#x003b3;-coronavirus [<xref rid="B12-molecules-25-05905" ref-type="bibr">12</xref>]. Six coronaviruses, including SARS-CoV (Severe Acute Respiratory Syndrome CoV) and MERS-CoV (Middle East Respiratory Syndrome CoV), were reported to cause illness in humans prior to SARS-CoV-2 [<xref rid="B13-molecules-25-05905" ref-type="bibr">13</xref>]. Similar to SARS-CoV and MERS-CoV, SARS-CoV-2 belongs to &#x003b2;-coronavirus. SARS-CoV-2 and SARS have a genome sequence homology of approximately 79% and is more closely related to SARS-like bat coronaviruses than SARS-CoV [<xref rid="B14-molecules-25-05905" ref-type="bibr">14</xref>]. The spike protein recognizes and binds to the receptor and invades the host cell <italic>via</italic> clathrin-mediated endocytosis [<xref rid="B15-molecules-25-05905" ref-type="bibr">15</xref>]. After internalization, the virus manipulates the cells&#x02019; reproductive machinery to produce more copies to infect other cells. SARS-CoV-2 also utilizes the cofactors, Furin and transmembrane proteases, serine 2 (TMPRSS2), protein cleaving enzymes, to cleave viral S-protein and further facilitate the virus-cell fusion [<xref rid="B16-molecules-25-05905" ref-type="bibr">16</xref>,<xref rid="B17-molecules-25-05905" ref-type="bibr">17</xref>]. As revealed in structure model analysis, SARS-CoV-2 binds to Angiotensin I Converting Enzyme 2 (ACE2), a host receptor, with more than a 10-fold higher affinity as compared to SARS-CoV [<xref rid="B18-molecules-25-05905" ref-type="bibr">18</xref>] (<xref ref-type="fig" rid="molecules-25-05905-f002">Figure 2</xref>B). These findings explain the greater propagation capacity of SARS-CoV-2 in humans relative to SARS-CoV and the higher number of reported cases of COVID-19 relative to SARS-CoV infection [<xref rid="B19-molecules-25-05905" ref-type="bibr">19</xref>]. The precise mechanism by which SARS-CoV-2 influences humans <italic>via</italic> S-protein binding to ACE2, the association intensity for the danger of human transmission, and how SARS-CoV-2 causes organ damage remains unclear, and further studies are required. </p></sec><sec id="sec3-molecules-25-05905"><title>3. Evidence for the Involvement of Liver in COVID-19 Infections</title><p>Early observational studies have shown the elevation in hepatic enzymes, including aspartate transferase, alanine transferase, and total bilirubin in COVID-19 patients [<xref rid="B20-molecules-25-05905" ref-type="bibr">20</xref>,<xref rid="B21-molecules-25-05905" ref-type="bibr">21</xref>,<xref rid="B22-molecules-25-05905" ref-type="bibr">22</xref>,<xref rid="B23-molecules-25-05905" ref-type="bibr">23</xref>,<xref rid="B24-molecules-25-05905" ref-type="bibr">24</xref>,<xref rid="B25-molecules-25-05905" ref-type="bibr">25</xref>,<xref rid="B26-molecules-25-05905" ref-type="bibr">26</xref>,<xref rid="B27-molecules-25-05905" ref-type="bibr">27</xref>] (<xref ref-type="fig" rid="molecules-25-05905-f002">Figure 2</xref>C). A study conducted by Chen et al. (2019) showed that more than a third of patients with COVID-19 have some liver function test abnormalities [<xref rid="B25-molecules-25-05905" ref-type="bibr">25</xref>]. It is uncertain if these laboratory test variations are linked with a poorer prognosis. In another study of 1099 patients from 552 hospitals, Guan and colleagues found elevated AST levels in 112 (18.2 percent) patients with non-serious disease and 56 (39.4 percent) patients with severe disease [<xref rid="B21-molecules-25-05905" ref-type="bibr">21</xref>]. In comparison, the proportion of pathological ALTs in severe cases (28.1%) was higher than in moderate cases (19.8%). Correspondingly, Huang et al. recorded that the proportion of ICU patients with liver damage (61.5%) was higher than non-ICU patients (25.0%) (25.0%) [<xref rid="B24-molecules-25-05905" ref-type="bibr">24</xref>]. Recent clinical trials of COVID-19 suggest that elevated transaminases, elevated bilirubin, prolonged prothrombin period, hypoproteinemia, and intensity of blood test abnormalities can predict a worse outcome [<xref rid="B28-molecules-25-05905" ref-type="bibr">28</xref>].</p></sec><sec id="sec4-molecules-25-05905"><title>4. Mechanism of Liver Injury in COVID-19</title><p>The exact mechanism of COVID-19 mediated liver injury is not fully known. In the following sections, various putative mechanisms involved in underlying hepatic injury are presented (<xref ref-type="fig" rid="molecules-25-05905-f003">Figure 3</xref>).</p><sec id="sec4dot1-molecules-25-05905"><title>4.1. Direct Effect of COVID-19 on Liver</title><p>As previously discussed, SARS-CoV-2 uses the ACE2 receptor for entry into the host cells, where the lung is the main target for infection. Reports from RNA-seq analysis have confirmed the expression of the ACE2 receptor in the liver. Studies have shown the expression of ACE2 receptor on liver tissues [<xref rid="B29-molecules-25-05905" ref-type="bibr">29</xref>]. Furthermore, liver histology of patients infected with COVID-19 reveals microvascular steatosis, multinuclear syncytial hepatocytes, and moderate lobular and portal activity [<xref rid="B30-molecules-25-05905" ref-type="bibr">30</xref>]. Moreover, mitochondrial swelling, endoplasmic reticulum dilatation, glycogen degradation, and damaged cell membranes are demonstrated by electron microscopy. These microscopic and ultrastructural characteristics co-occur with the SARS-CoV-2&#x02019;s cytopathic influence on hepatocytes, suggesting its role for the viral replication within liver cells [<xref rid="B31-molecules-25-05905" ref-type="bibr">31</xref>].</p></sec><sec id="sec4dot2-molecules-25-05905"><title>4.2. Cytokine Storm Mediated Hepatic Damage</title><p>It is observed that the host body activates an immune response against SARS-CoV-2 infection to facilitate virus clearance and induce a sustained adaptive immune response. Moreover, serologic analysis has shown elevated levels of Th17, CD8+ T-cells, IL-2, IL-6, IL-10, TNF-&#x003b1;, GM-CSF, MCP-1, and macrophage inflammatory protein 1 &#x003b1; in patients with severe COVID-19 infection, as compared to those in control [<xref rid="B24-molecules-25-05905" ref-type="bibr">24</xref>,<xref rid="B32-molecules-25-05905" ref-type="bibr">32</xref>,<xref rid="B33-molecules-25-05905" ref-type="bibr">33</xref>,<xref rid="B34-molecules-25-05905" ref-type="bibr">34</xref>]. Understandably, these SARS-CoV-2 associated cytokine storms can damage many organs, including the liver and gut. Many patients eventually died following organ failure [<xref rid="B35-molecules-25-05905" ref-type="bibr">35</xref>]. In a recent meta-analysis, the prevalence of chronic liver disease (CLD) patients (73 studies, 24,299 patients) was 3% among all COVID-19 patients [<xref rid="B36-molecules-25-05905" ref-type="bibr">36</xref>]. The prevalence of CLD patients was similar in COVID-19 positive and negative populations (pooled OR 0.79 [95% CI 0.60, 1.05], <italic>p</italic> = 0.10). The presence of CLD was significantly associated with more severe COVID-19 infection (pooled OR 1.48 [95% CI 1.17, 1.87], <italic>p</italic> = 0.001) and overall mortality (pooled OR 1.78 [95% CI 1.09, 2.93], <italic>p</italic> = 0.02) [<xref rid="B36-molecules-25-05905" ref-type="bibr">36</xref>].</p></sec><sec id="sec4dot3-molecules-25-05905"><title>4.3. Hypoxia Associated Liver Damage </title><p>Extensive release of cytokines by the immune system in response to viral infection often results in sepsis symptoms, which caused mortality in 28% of COVID-19 cases [<xref rid="B3-molecules-25-05905" ref-type="bibr">3</xref>]. Sepsis is generally referred to as the dysregulated immune response to an infection that results in multiple organ dysfunction [<xref rid="B37-molecules-25-05905" ref-type="bibr">37</xref>]. The pathophysiology of sepsis-associated liver injury involves hypoxic liver injury due to several factors, including ischemia and shock, cholestasis, and overwhelming inflammation [<xref rid="B38-molecules-25-05905" ref-type="bibr">38</xref>]. It is observed that sepsis is not uncommon in patients with existing liver cirrhosis [<xref rid="B39-molecules-25-05905" ref-type="bibr">39</xref>], suggesting that pneumonia associated hypoxia is one of the most significant factors causing secondary liver injury in COVID-19 patients.</p></sec><sec id="sec4dot4-molecules-25-05905"><title>4.4. Antiviral Induced Hepatotoxicity</title><p>Microvascular steatosis and mild lobular and portal activities in postmortem biopsies reveal that liver injury is either caused by SARS-CoV-2 infection or drug-induced toxicity [<xref rid="B30-molecules-25-05905" ref-type="bibr">30</xref>]. In another study, it was observed that antiviral therapies, including lopinavir/ritonavir used for the treatment of COVID-19, induces liver injury in patients [<xref rid="B40-molecules-25-05905" ref-type="bibr">40</xref>]. Therefore, hepatic enzyme defects arose following the usage of a hepatotoxic medication; and antiviral induced damage may first be verified or removed.</p></sec><sec id="sec4dot5-molecules-25-05905"><title>4.5. Antipyretics Induced Hepatotoxicity</title><p>Many affected people were administered with antipyretic agents for fever relief during the COVID-19 outbreak. Many of these medicines include acetaminophen, a medication believed to inflict serious harm to the liver and/or trigger liver failure [<xref rid="B30-molecules-25-05905" ref-type="bibr">30</xref>]. Acetaminophen is also known as APAP (acetyl-para-aminophenol) in the USA and paracetamol in Europe, is one of the most widely used antipyretics and analgesics medications in the world [<xref rid="B41-molecules-25-05905" ref-type="bibr">41</xref>].</p></sec><sec id="sec4dot6-molecules-25-05905"><title>4.6. Pre-Existing Liver Disease Leads to Worst COVID-19 Outcome</title><p>Due to systemic immunodeficiency, patients with chronic liver disease and cirrhosis may have a higher risk of COVID-19 infections [<xref rid="B42-molecules-25-05905" ref-type="bibr">42</xref>]. Moreover, a post-transplant patient is at higher risk due to immunosuppressive therapy [<xref rid="B43-molecules-25-05905" ref-type="bibr">43</xref>,<xref rid="B44-molecules-25-05905" ref-type="bibr">44</xref>]. However, the relationship between underlying liver disease and COVID-19 has not been fully studied. Patients with cirrhosis are at an increased risk of decompensation or development of acute-on-chronic liver failure when coupled with a bacterial, fungal, or viral infection [<xref rid="B45-molecules-25-05905" ref-type="bibr">45</xref>,<xref rid="B46-molecules-25-05905" ref-type="bibr">46</xref>]. Co-morbidities, including coronary artery disease, cerebrovascular disease, and chronic obstructive pulmonary disease, are more prevalent in hospitalized patients with severe/critical illnesses from COVID-19, and these patients are more likely to manifest abnormal liver chemistries [<xref rid="B47-molecules-25-05905" ref-type="bibr">47</xref>]. Therefore, special attention should be paid to monitoring hepatic changes triggered by COVID-19 in patients with a pre-existing history of liver disease (especially older patients).</p></sec></sec><sec id="sec5-molecules-25-05905"><title>5. Hepatoprotective Agents</title><p>Most of the drugs are metabolized in the liver. As a result, liver injury can occur even though they are consumed for therapeutic purposes [<xref rid="B48-molecules-25-05905" ref-type="bibr">48</xref>]. Since liver injury may result in fatty liver, hepatitis, fibrosis, cirrhosis, and cancer, this is considered as a serious health concern. Accumulated studies have reported that herbal compounds possess numerous medicinal properties. Natural products and nutraceuticals have shown potent therapeutic activity in liver injuries caused by several toxicants and drugs [<xref rid="B49-molecules-25-05905" ref-type="bibr">49</xref>,<xref rid="B50-molecules-25-05905" ref-type="bibr">50</xref>,<xref rid="B51-molecules-25-05905" ref-type="bibr">51</xref>,<xref rid="B52-molecules-25-05905" ref-type="bibr">52</xref>,<xref rid="B53-molecules-25-05905" ref-type="bibr">53</xref>]. This section summarizes selective natural bioactive nutraceuticals exhibiting the hepatoprotective activity and pays specific attention to toxicants/antiviral induced liver injury (<xref ref-type="fig" rid="molecules-25-05905-f004">Figure 4</xref>). Few of these have shown potent antiviral activities and may be used in the future as possible options for the COVID-19 treatment </p><sec id="sec5dot1-molecules-25-05905"><title>5.1. Silybum Marianum</title><p><italic>Silybum marianum</italic> belongs to the <italic>Asteraceae</italic> family and is native to the Mediterranean region. It is commonly known as milk thistle. This plant has thorny branches and milky sap, with oval leaves of up to 30 cm. The flowers are light pink in colors and can be up to 8 cm in diameter [<xref rid="B54-molecules-25-05905" ref-type="bibr">54</xref>]. This plant is grown in Hungary, China, and South America. In Mexico, milk thistle is consumed as a nutritional substitute [<xref rid="B55-molecules-25-05905" ref-type="bibr">55</xref>]. Silymarin is a naturally occurring compound found in <italic>Silybum marianum</italic> and is most notably composed of numerous flavolignans, including silybin, silydianin, and silychristine. Silybin constitutes approximately 50% to 70% of silymarin extracts. This plant possesses several pharmacological activities and is used to treat disorders related to the liver, gall bladder, and spleen [<xref rid="B56-molecules-25-05905" ref-type="bibr">56</xref>]. Notably, because of its antioxidant, anti-inflammatory, and anti-fibrotic activities, silymarin is probably the most commonly used natural compound for hepatic disease care worldwide [<xref rid="B57-molecules-25-05905" ref-type="bibr">57</xref>]. Most importantly, its medicinal property has been explored as hepatoprotective for supportive therapy in case of hepatic dysfunctions such as hepatitis, cirrhosis, and fatty liver [<xref rid="B58-molecules-25-05905" ref-type="bibr">58</xref>,<xref rid="B59-molecules-25-05905" ref-type="bibr">59</xref>]. Moreover, studies have shown that <italic>Silybum marianum</italic> is very potent against stress induced by toxicants, including poisonous mushrooms, alcohol, and toxic chemicals [<xref rid="B60-molecules-25-05905" ref-type="bibr">60</xref>]. Bioactive components isolated from <italic>Silybum</italic> spp., silymarin, showed therapeutic benefits in acute and chronic viral, alcohol, and chemically induced hepatitis [<xref rid="B61-molecules-25-05905" ref-type="bibr">61</xref>]. Silymarin is the most frequently used natural compound for treating hepatic diseases worldwide due to its antioxidant, anti-inflammatory, and anti-fibrotic activities. Inhibition of cyclooxygenase cycle, leukotrienes, and free radical production contribute to its cytoprotective effects in liver [<xref rid="B62-molecules-25-05905" ref-type="bibr">62</xref>].</p><p>Silymarin has also been known to increase protein synthesis in hepatocytes [<xref rid="B57-molecules-25-05905" ref-type="bibr">57</xref>]. Owing to its phenolic existence, it can give electrons to stabilize free radicals and reactive oxygen molecules [<xref rid="B63-molecules-25-05905" ref-type="bibr">63</xref>]. Silymarin also modulates intracellular glutathione, which inhibits membranes from lipid peroxidation [<xref rid="B64-molecules-25-05905" ref-type="bibr">64</xref>]. Silymarin also has antiviral effects as it affects RNA and DNA synthesis [<xref rid="B65-molecules-25-05905" ref-type="bibr">65</xref>]. Eurasil 85 is a strong oral bioavailable silymarin formulation with potent antioxidant activity are found in clinical studies, and co-administration with several antiretrovirals has been shown to be safe [<xref rid="B66-molecules-25-05905" ref-type="bibr">66</xref>,<xref rid="B67-molecules-25-05905" ref-type="bibr">67</xref>]. Although the use of silymarin in the management of hepatic dysfunctions remains a historical interest, its utility in the management of SAR-COV-2 induced liver dysfunction should be explored [<xref rid="B68-molecules-25-05905" ref-type="bibr">68</xref>].</p></sec><sec id="sec5dot2-molecules-25-05905"><title>5.2. Solanum Nigrum</title><p><italic>Solanum nigrum</italic> is commonly known as &#x0201c;Black nightshade&#x0201d; and is often cultivated in open, wild temperate climate regions [<xref rid="B69-molecules-25-05905" ref-type="bibr">69</xref>,<xref rid="B70-molecules-25-05905" ref-type="bibr">70</xref>,<xref rid="B71-molecules-25-05905" ref-type="bibr">71</xref>]. This also constitutes food crops in several developing countries [<xref rid="B72-molecules-25-05905" ref-type="bibr">72</xref>]. <italic>Solanum nigrum</italic> has numerous medicinal properties [<xref rid="B73-molecules-25-05905" ref-type="bibr">73</xref>]. In traditional medicine, plant leaves have reportedly been used to treat many illnesses, including seizures, asthma, nausea, ulcers, vomiting, diarrhea, some eye infections, and jaundice [<xref rid="B74-molecules-25-05905" ref-type="bibr">74</xref>,<xref rid="B75-molecules-25-05905" ref-type="bibr">75</xref>]. The extracts contain many polyphenolic compounds, such as phenolic acids and flavones [<xref rid="B76-molecules-25-05905" ref-type="bibr">76</xref>]. This herb is used as a potential hepatoprotective agent [<xref rid="B69-molecules-25-05905" ref-type="bibr">69</xref>,<xref rid="B70-molecules-25-05905" ref-type="bibr">70</xref>,<xref rid="B71-molecules-25-05905" ref-type="bibr">71</xref>]. It exhibits several antioxidant activities and is known to inhibit lipid peroxidation as a means for their mechanism of action [<xref rid="B77-molecules-25-05905" ref-type="bibr">77</xref>,<xref rid="B78-molecules-25-05905" ref-type="bibr">78</xref>]. Aqueous extract of <italic>S. nigrum</italic> has been shown to reduce hepatic enzymes ALT, AST, and ALP significantly. Moreover, this inhibits bilirubin&#x02019;s level and scavenge the free radicals production, as observed in CCL<sub>4</sub> induced hepatic damage in rats [<xref rid="B79-molecules-25-05905" ref-type="bibr">79</xref>]. The antioxidant activity may be attributable to the polyphenolic compounds&#x02019; existence in stems and leaves [<xref rid="B80-molecules-25-05905" ref-type="bibr">80</xref>].</p></sec><sec id="sec5dot3-molecules-25-05905"><title>5.3. Cichorium Intybus</title><p>The plant <italic>Cichorium intybus,</italic> commonly known as &#x0201c;chicory&#x0201d;, is indigenous to Western Asia, Egypt, North America, and Europe [<xref rid="B81-molecules-25-05905" ref-type="bibr">81</xref>]. This displays several therapeutic properties including anti-microbial [<xref rid="B82-molecules-25-05905" ref-type="bibr">82</xref>,<xref rid="B83-molecules-25-05905" ref-type="bibr">83</xref>], immunomodulatory [<xref rid="B84-molecules-25-05905" ref-type="bibr">84</xref>], antihepatotoxic [<xref rid="B85-molecules-25-05905" ref-type="bibr">85</xref>,<xref rid="B86-molecules-25-05905" ref-type="bibr">86</xref>,<xref rid="B87-molecules-25-05905" ref-type="bibr">87</xref>] and anti-hypertiglycemia activities [<xref rid="B88-molecules-25-05905" ref-type="bibr">88</xref>]. <italic>Chichorium intybus</italic> extract showed remarkable antioxidative effects <italic>via</italic> inhibition of thiobarbituric acid reactive substances production [<xref rid="B89-molecules-25-05905" ref-type="bibr">89</xref>]. Notably, it has been used in many liver tonics for the ailment of the liver and digestive disorders [<xref rid="B90-molecules-25-05905" ref-type="bibr">90</xref>]. The root extract of <italic>C. intybus</italic> has shown anti-hepatotoxic activity against CCL<sub>4</sub>-induced hepatic damage as demonstrated by decreased levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and bilirubin in treated groups as compared to control groups [<xref rid="B91-molecules-25-05905" ref-type="bibr">91</xref>]. Interestingly, Zhang et al. (2014) studied the anti-hepatitis activity of chicoric acid isolated from <italic>Chichorium intybus</italic> leaves and observed that it can block the viral protein and DNA synthesis [<xref rid="B92-molecules-25-05905" ref-type="bibr">92</xref>].</p></sec><sec id="sec5dot4-molecules-25-05905"><title>5.4. Allium Sativum</title><p><italic>Allium sativum</italic> has been used for more than 5000 years and is commonly known as garlic. <italic>Allium sativum</italic> is used as a spice and has numerous medicinal properties. The active components present in this plant are diallyl thiosulfinate and diallyl disulfide. Studies have reported that pretreatment with extracts restored antioxidant enzyme levels in GalN/LPS-treated hepatitis in animal models [<xref rid="B93-molecules-25-05905" ref-type="bibr">93</xref>]. Furthermore, it is known to attenuate the nitric oxide-induced oxidative stress, and lipid peroxidation in CCL<sub>4</sub> treated mice [<xref rid="B94-molecules-25-05905" ref-type="bibr">94</xref>]. Garlic oil has also reduced serum AST, ALT, alkaline phosphatase (ALP), and gamma-glutamyl transferase (GGT) levels in CCL4-induced hepatotoxicity [<xref rid="B95-molecules-25-05905" ref-type="bibr">95</xref>]. It has diverse pharmacological activities, including antibacterial, antiviral, antioxidant effects, anti-mutagenic, and immune-modulatory properties [<xref rid="B96-molecules-25-05905" ref-type="bibr">96</xref>,<xref rid="B97-molecules-25-05905" ref-type="bibr">97</xref>].</p></sec><sec id="sec5dot5-molecules-25-05905"><title>5.5. Glycyrrhiza Glabra</title><p><italic>Glycyrrhiza glabra,</italic> commonly known as licorice, is native to the Mediterranean region, Western Asia and Europe. This plant is a very effective treatment for chest disease and asthma [<xref rid="B56-molecules-25-05905" ref-type="bibr">56</xref>]. Studies have shown hepatoprotective activity of <italic>G. glabra</italic> in CCL<sub>4</sub> induced hepatic damage. Following the oral administration, the level of hepatic iNOS, COX2, and TNF-alpha were significantly reduced in the treated group compared to the control group [<xref rid="B98-molecules-25-05905" ref-type="bibr">98</xref>]. In another study, Kimura et al. showed that <italic>G. glabra</italic> is effective in attenuating the serum AST and ALT levels [<xref rid="B99-molecules-25-05905" ref-type="bibr">99</xref>]. Glycyrrhizin, is a triterpenoid saponin, predominantly present in plant roots and possesses numerous pharmacological activities [<xref rid="B100-molecules-25-05905" ref-type="bibr">100</xref>,<xref rid="B101-molecules-25-05905" ref-type="bibr">101</xref>,<xref rid="B102-molecules-25-05905" ref-type="bibr">102</xref>]. Interestingly, several studies have shown that glycyrrhizin exhibits potent activity against various human viruses [<xref rid="B103-molecules-25-05905" ref-type="bibr">103</xref>,<xref rid="B104-molecules-25-05905" ref-type="bibr">104</xref>,<xref rid="B105-molecules-25-05905" ref-type="bibr">105</xref>,<xref rid="B106-molecules-25-05905" ref-type="bibr">106</xref>,<xref rid="B107-molecules-25-05905" ref-type="bibr">107</xref>,<xref rid="B108-molecules-25-05905" ref-type="bibr">108</xref>,<xref rid="B109-molecules-25-05905" ref-type="bibr">109</xref>,<xref rid="B110-molecules-25-05905" ref-type="bibr">110</xref>,<xref rid="B111-molecules-25-05905" ref-type="bibr">111</xref>,<xref rid="B112-molecules-25-05905" ref-type="bibr">112</xref>,<xref rid="B113-molecules-25-05905" ref-type="bibr">113</xref>,<xref rid="B114-molecules-25-05905" ref-type="bibr">114</xref>,<xref rid="B115-molecules-25-05905" ref-type="bibr">115</xref>,<xref rid="B116-molecules-25-05905" ref-type="bibr">116</xref>]. Studies have shown the glycyrrhizin is used alone or in combination with other medications to combat coronavirus infections [<xref rid="B117-molecules-25-05905" ref-type="bibr">117</xref>]. Recently, one study showed its ability to bind ACE2 that represses the SARS-CoV-2 receptor. Thus, targeting of ACE2 may also be very useful to prevent diffusion out of the virus from infected cells and invading new cells [<xref rid="B118-molecules-25-05905" ref-type="bibr">118</xref>].</p></sec><sec id="sec5dot6-molecules-25-05905"><title>5.6. Phyllanthus Amarus</title><p><italic>Phyllanthus amarus</italic> is a small plant and is commonly found in tropical regions and is used in many traditional medicines due to its diverse pharmacological activities [<xref rid="B119-molecules-25-05905" ref-type="bibr">119</xref>]. Lignan phyllanthin, one of its essential bioactive constituents, has shown very potent activity as a hepatoprotective agent [<xref rid="B120-molecules-25-05905" ref-type="bibr">120</xref>]. Histopathological analysis revealed that ethanolic extract of <italic>P. amarus</italic> attenuates the generation of intracellular ROS by enhancing the antioxidant levels against aflatoxin B<sub>1</sub>-induced hepatotoxicity [<xref rid="B121-molecules-25-05905" ref-type="bibr">121</xref>]. Furthermore, an aqueous extract of <italic>P. amarus</italic> has been shown to inhibit HBV DNA polymerase activity as seen in in vitro experimental conditions, suggesting its potential use for viral infections in the liver [<xref rid="B122-molecules-25-05905" ref-type="bibr">122</xref>]. Phytochemical screening of <italic>P. muellarianus</italic>, displayed the presence of several bioactive ingredients such as furosin, isoquercetin, phaselic acid, corilagin, nitidine, geranin, and gallic acid [<xref rid="B123-molecules-25-05905" ref-type="bibr">123</xref>,<xref rid="B124-molecules-25-05905" ref-type="bibr">124</xref>]. Aqueous extract of the <italic>P. muellarianus</italic> leaf has shown hepatoprotective activity against damage induced by p-acetaminophen in swiss albino mice [<xref rid="B125-molecules-25-05905" ref-type="bibr">125</xref>]. It was observed that extract (<italic>p</italic> &#x0003e; 0.05) significantly attenuated acetaminophen-mediated alterations in ALT, alkaline phosphatase (ALP), AST, albumin (ALB), and total bilirubin (TB). Gallic acid, a well-known antioxidant agent, was documented to reverse AST, ALT, and ALP in acetaminophen-induced liver toxicity [<xref rid="B126-molecules-25-05905" ref-type="bibr">126</xref>].</p></sec><sec id="sec5dot7-molecules-25-05905"><title>5.7. Withania Somnifera</title><p><italic>Withania somnifera</italic> belongs to the family of <italic>Solanaceae</italic> and is commonly known as ashwagandha, Indian ginseng, or Winter cherry. Multiple parts of this medicinal plant, such as leaves, fruits, and stems, have therapeutic effects [<xref rid="B127-molecules-25-05905" ref-type="bibr">127</xref>]. The popular bioactive ingredients present in this are withaferin A and withanolides. Several studies have shown the hepatoprotective activity of this plant without toxicity [<xref rid="B127-molecules-25-05905" ref-type="bibr">127</xref>,<xref rid="B128-molecules-25-05905" ref-type="bibr">128</xref>]. Withaferin A performs a crucial function as antiviral agents against several viruses, including HIV-1 [<xref rid="B129-molecules-25-05905" ref-type="bibr">129</xref>], HPV [<xref rid="B130-molecules-25-05905" ref-type="bibr">130</xref>], HSV [<xref rid="B131-molecules-25-05905" ref-type="bibr">131</xref>], and infectious bursal diseases virus (IBDV) [<xref rid="B131-molecules-25-05905" ref-type="bibr">131</xref>]. In a recent study, it has been reported that withaferin-A and withanone could bind and stably interact with the catalytic site of TMPRSS2, suggesting their use in the blocking of COVID-19 viral entry into host cells [<xref rid="B132-molecules-25-05905" ref-type="bibr">132</xref>].</p></sec><sec id="sec5dot8-molecules-25-05905"><title>5.8. Curcuma Longa</title><p><italic>Curcuma longa</italic> is a very famous spice native to India and Southeast Asia. This plant has diverse pharmacological activity, including antibacterial, antifungal, antiviral, and anticancer activities [<xref rid="B133-molecules-25-05905" ref-type="bibr">133</xref>]. Curcumin (diferuloylmethane), a polyphenol present in this plant&#x02019;s rhizome, is responsible for its therapeutic activity [<xref rid="B134-molecules-25-05905" ref-type="bibr">134</xref>,<xref rid="B135-molecules-25-05905" ref-type="bibr">135</xref>]. The hepatoprotective function of curcumin depends primarily on its strong anti-inflammatory and antioxidant effects. It also exhibits immunomodulatory activity by suppressing the production of cytokines IFN-gamma, ILs, and TNF-alpha. Curcumin is a very effective blocker of NF-kappa B and inhibits the synthesis of iNOS [<xref rid="B136-molecules-25-05905" ref-type="bibr">136</xref>,<xref rid="B137-molecules-25-05905" ref-type="bibr">137</xref>,<xref rid="B138-molecules-25-05905" ref-type="bibr">138</xref>]. Research has also shown that curcumin inhibits hepatic stellate cell activation and collagen expression. Moreover, it has shown hepatoprotective effects in thioacetamide-induced liver injury and fibrosis [<xref rid="B139-molecules-25-05905" ref-type="bibr">139</xref>]. Curcumin has also been reported to conduct antiviral activities against a large variety of viruses, including HIV-1, HSV-2, HPV and hepatitis virus [<xref rid="B140-molecules-25-05905" ref-type="bibr">140</xref>,<xref rid="B141-molecules-25-05905" ref-type="bibr">141</xref>].</p></sec><sec id="sec5dot9-molecules-25-05905"><title>5.9. Other Hepatoprotective Agents</title><p><italic>Capparis spinosa,</italic> generally found in west and Central Asia, is commonly used as a cooking flavoring agent [<xref rid="B142-molecules-25-05905" ref-type="bibr">142</xref>]. Several traditional medicines utilize this plant for the treatment of liver diseases [<xref rid="B143-molecules-25-05905" ref-type="bibr">143</xref>]. This possesses numerous bioactivities, including antioxidant, anticancer, and antibacterial properties. It has been demonstrated that polyphenol present in the plant is responsible for its therapeutic activity. Liv-52, an Indian herbal preparation for liver disorders, also contains <italic>Capparis spinosa,</italic> an essential constituent [<xref rid="B144-molecules-25-05905" ref-type="bibr">144</xref>]. Studies suggest that Liv-52 showed significant therapeutic effects in cirrhotic patients [<xref rid="B144-molecules-25-05905" ref-type="bibr">144</xref>]. Additionally, the chemical constituent p-methoxy benzoic acid, from the aqueous extract of <italic>C. spinosa,</italic> expresses potent hepatoprotective activity against paracetamol and CCL<sub>4</sub>-induced hepatotoxicity [<xref rid="B145-molecules-25-05905" ref-type="bibr">145</xref>].</p><p><italic>Aquilaria agallocha</italic> has several properties, including pharmacological effects, and shows anticancer, antioxidant, anti-inflammatory, antidiabetic, analgesic, antipyretic, laxative, antidiabetic, antimicrobial, antibacterial, and anticonvulsant protective activities [<xref rid="B146-molecules-25-05905" ref-type="bibr">146</xref>]. The hepatoprotective effects of the ethanolic extract of <italic>A. agallocha</italic> leaves in PCM-induced hepatotoxicity in Sprague&#x02013;Dawley (SD) rats show a substantial decrease in AST, ALP, ALT, lactate dehydrogenase (LDH), CHL, TB, and an increase in ALB, total protein concentration, and prevention of PCM-induced histopathological changes in the liver [<xref rid="B147-molecules-25-05905" ref-type="bibr">147</xref>].</p><p><italic>Dodonaea viscosa</italic> belongs to the soapberry family and is widely distributed in the subtropical, warm, tropical, temperate regions of Africa, the Americas, Australia, and Southern Asia. Aqueous: methanolic (70:30) leaves extract of <italic>D. viscosa</italic> has shown to exhibit the hepatoprotective activity by reducing the serum level of TAG, total cholesterol, LDL-C, HDL-CHL, ALT, and AST compared to experimental control sample [<xref rid="B148-molecules-25-05905" ref-type="bibr">148</xref>]. Another plant <italic>Salix caprea,</italic> referred to as goat willow, is a predominant species of willow in Europe and western/central Asia [<xref rid="B149-molecules-25-05905" ref-type="bibr">149</xref>]. The detailed knowledge of various natural compounds&#x02019; hepatoprotective activity has been summarized in the review [<xref rid="B150-molecules-25-05905" ref-type="bibr">150</xref>].</p><p>Ethanolic extract of <italic>Salix subserrata</italic> has shown significant hepatoprotective activity in CCl<sub>4</sub>-induced liver toxicity [<xref rid="B149-molecules-25-05905" ref-type="bibr">149</xref>] by decreasing serum enzymes levels and reversing hepatic tissue damage caused by CCl<sub>4</sub>. Studies have shown that the hepatoprotective activity of ethanolic <italic>Pandanus odoratissimus</italic> roots extracts in PCM-induced hepatotoxicity in rats resulted in a substantial decrease in the higher levels of serum marker enzymes [<xref rid="B151-molecules-25-05905" ref-type="bibr">151</xref>]. Another plant named <italic>Alocasia indica,</italic> commonly cultivated especially in West Bengal, Assam, Maharashtra, and Southern India, has been assessed for hepatoprotective activity in CCL<sub>4</sub>-induced hepatic injury in male Albino Wistar rats [<xref rid="B152-molecules-25-05905" ref-type="bibr">152</xref>]. It has been reported that the antioxidant activity of this plant has the potential for designing drugs for liver diseases. <italic>Opuntia ficus-indica,</italic> another plant, is a cactus species that are commonly distributed in the arid and semiarid parts of the world and is believed to have originated from Mexico. Aqueous extract (2 mL/kg) from the cactus leaves (cladodes) has shown potent hepatoprotective activity in CCl<sub>4</sub>-induced toxicity in Wistar male rats by decreasing AST and ALT levels [<xref rid="B153-molecules-25-05905" ref-type="bibr">153</xref>]. The use of these natural phytoagents or nutraceuticals alone or in combination may protect the liver and modulates coronavirus infection, and provide recommendations for further study.</p></sec></sec><sec sec-type="conclusions" id="sec6-molecules-25-05905"><title>6. Conclusions</title><p>The COVID-19 pandemic has resulted in a global crisis in public health. As noted in COVID-19 patients, liver injury is very common, caused by either direct or indirect damage to organs, including the overshooting inflammatory response. Importantly, the drug-induced liver injury should not be overlooked during coronavirus infection treatment and should be carefully studied. Ultimately, it is imperative to find alternative methods for hepatoprotection. This review provides information on the medicinal plants used for various hepatic disorders over several decades. It also highlights the pathways that these plant-based medicines can seek to reduce the burden of disease. The potential efficacy of these bioactive nutraceuticals should be explored in COVID-19 patients and at-risk populations.</p></sec></body><back><ack><title>Acknowledgments</title><p>We want to thank Molly K. Vela for helping with manuscript proofreading.</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Authors M.S. and S.M. worked on the conceptualization, information compilation, analysis, and manuscript writing equally. Review and editing, A.R., M.M.Y., A.S.N., S.K.S., V.D., S.C.C., and M.J. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>The authors acknowledge the support by the National Institutes of Health (R01 CA210192, R01 CA206069, R01 CA204552) and partial support from the Herb Kosten Foundation, and Faculty Start-up fund from UTRGV to S.C.C., M.J., and M.M.Y.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-25-05905"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perricone</surname><given-names>C.</given-names></name><name><surname>Triggianese</surname><given-names>P.</given-names></name><name><surname>Bartoloni</surname><given-names>E.</given-names></name><name><surname>Cafaro</surname><given-names>G.</given-names></name><name><surname>Bonifacio</surname><given-names>A.F.</given-names></name><name><surname>Bursi</surname><given-names>R.</given-names></name><name><surname>Perricone</surname><given-names>R.</given-names></name><name><surname>Gerli</surname><given-names>R.</given-names></name></person-group><article-title>The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19</article-title><source>J. Autoimmun.</source><year>2020</year><volume>111</volume><fpage>102468</fpage><pub-id pub-id-type="doi">10.1016/j.jaut.2020.102468</pub-id><?supplied-pmid 32317220?><pub-id pub-id-type="pmid">32317220</pub-id></element-citation></ref><ref id="B2-molecules-25-05905"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stebbing</surname><given-names>J.</given-names></name><name><surname>Phelan</surname><given-names>A.</given-names></name><name><surname>Griffin</surname><given-names>I.</given-names></name><name><surname>Tucker</surname><given-names>C.</given-names></name><name><surname>Oechsle</surname><given-names>O.</given-names></name><name><surname>Smith</surname><given-names>D.</given-names></name><name><surname>Richardson</surname><given-names>P.</given-names></name></person-group><article-title>COVID-19: Combining antiviral and anti-inflammatory treatments</article-title><source>Lancet Infect. Dis.</source><year>2020</year><volume>20</volume><fpage>400</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30132-8</pub-id><pub-id pub-id-type="pmid">32113509</pub-id></element-citation></ref><ref id="B3-molecules-25-05905"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tay</surname><given-names>M.Z.</given-names></name><name><surname>Poh</surname><given-names>C.M.</given-names></name><name><surname>R&#x000e9;nia</surname><given-names>L.</given-names></name><name><surname>MacAry</surname><given-names>P.A.</given-names></name><name><surname>Ng</surname><given-names>L.F.P.</given-names></name></person-group><article-title>The trinity of COVID-19: Immunity, inflammation and intervention</article-title><source>Nat. Rev. Immunol.</source><year>2020</year><volume>20</volume><fpage>363</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-0311-8</pub-id><?supplied-pmid 32346093?><pub-id pub-id-type="pmid">32346093</pub-id></element-citation></ref><ref id="B4-molecules-25-05905"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizumoto</surname><given-names>K.</given-names></name><name><surname>Kagaya</surname><given-names>K.</given-names></name><name><surname>Zarebski</surname><given-names>A.</given-names></name><name><surname>Chowell</surname><given-names>G.</given-names></name></person-group><article-title>Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020</article-title><source>Eurosurveillance</source><year>2020</year><volume>25</volume><fpage>2000180</fpage><pub-id pub-id-type="doi">10.2807/1560-7917.ES.2020.25.10.2000180</pub-id><?supplied-pmid 32183930?><pub-id pub-id-type="pmid">32183930</pub-id></element-citation></ref><ref id="B5-molecules-25-05905"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laskar</surname><given-names>P.</given-names></name><name><surname>Yallapu</surname><given-names>M.M.</given-names></name><name><surname>Chauhan</surname><given-names>S.C.</given-names></name></person-group><article-title>&#x0201c;Tomorrow Never Dies&#x0201d;: Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies</article-title><source>Diseases</source><year>2020</year><volume>8</volume><elocation-id>30</elocation-id><pub-id pub-id-type="doi">10.3390/diseases8030030</pub-id><?supplied-pmid 32781617?><pub-id pub-id-type="pmid">32781617</pub-id></element-citation></ref><ref id="B6-molecules-25-05905"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiersinga</surname><given-names>W.J.</given-names></name><name><surname>Rhodes</surname><given-names>A.</given-names></name><name><surname>Cheng</surname><given-names>A.C.</given-names></name><name><surname>Peacock</surname><given-names>S.J.</given-names></name><name><surname>Prescott</surname><given-names>H.C.</given-names></name></person-group><article-title>Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review</article-title><source>Jama</source><year>2020</year><volume>324</volume><fpage>782</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.1001/jama.2020.12839</pub-id><?supplied-pmid 32648899?><pub-id pub-id-type="pmid">32648899</pub-id></element-citation></ref><ref id="B7-molecules-25-05905"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Xiao</surname><given-names>S.</given-names></name></person-group><article-title>Hepatic involvement in COVID-19 patients: Pathology, pathogenesis, and clinical implications</article-title><source>J. Med Virol.</source><year>2020</year><volume>92</volume><fpage>1491</fpage><lpage>1494</lpage><pub-id pub-id-type="doi">10.1002/jmv.25973</pub-id><pub-id pub-id-type="pmid">32369204</pub-id></element-citation></ref><ref id="B8-molecules-25-05905"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musa</surname><given-names>S.</given-names></name></person-group><article-title>Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?</article-title><source>Arab. J. Gastroenterol.</source><year>2020</year><volume>21</volume><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.ajg.2020.03.002</pub-id><pub-id pub-id-type="pmid">32253172</pub-id></element-citation></ref><ref id="B9-molecules-25-05905"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>N.</given-names></name><name><surname>Jaggi</surname><given-names>M.</given-names></name><name><surname>Chauhan</surname><given-names>S.C.</given-names></name><name><surname>Yallapu</surname><given-names>M.M.</given-names></name></person-group><article-title>COVID-19: Fighting the invisible enemy with microRNAs</article-title><source>Expert Rev. Anti-Infective Ther.</source><year>2020</year><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1080/14787210.2020.1812385</pub-id></element-citation></ref><ref id="B10-molecules-25-05905"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashyap</surname><given-names>V.K.</given-names></name><name><surname>Dhasmana</surname><given-names>A.</given-names></name><name><surname>Massey</surname><given-names>A.</given-names></name><name><surname>Kotnala</surname><given-names>S.</given-names></name><name><surname>Zafar</surname><given-names>N.</given-names></name><name><surname>Jaggi</surname><given-names>M.</given-names></name><name><surname>Yallapu</surname><given-names>M.M.</given-names></name><name><surname>Chauhan</surname><given-names>S.C.</given-names></name></person-group><article-title>Smoking and COVID-19: Adding Fuel to the Flame</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>6581</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21186581</pub-id></element-citation></ref><ref id="B11-molecules-25-05905"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>COVID-19: A new challenge for human beings</article-title><source>Cell Mol. Immunol.</source><year>2020</year><volume>17</volume><fpage>555</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1038/s41423-020-0407-x</pub-id><?supplied-pmid 32235915?><pub-id pub-id-type="pmid">32235915</pub-id></element-citation></ref><ref id="B12-molecules-25-05905"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>J.F.-W.</given-names></name><name><surname>To</surname><given-names>K.K.-W.</given-names></name><name><surname>Tse</surname><given-names>H.</given-names></name><name><surname>Jin</surname><given-names>D.-Y.</given-names></name><name><surname>Yuen</surname><given-names>K.-Y.</given-names></name></person-group><article-title>Interspecies transmission and emergence of novel viruses: Lessons from bats and birds</article-title><source>Trends Microbiol.</source><year>2013</year><volume>21</volume><fpage>544</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2013.05.005</pub-id><?supplied-pmid 23770275?><pub-id pub-id-type="pmid">23770275</pub-id></element-citation></ref><ref id="B13-molecules-25-05905"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>B.</given-names></name><name><surname>Shi</surname><given-names>W.</given-names></name><name><surname>Lu</surname><given-names>R.</given-names></name><etal/></person-group><article-title>A Novel Coronavirus from Patients with Pneumonia in China, 2019</article-title><source>N. Engl. J. Med.</source><year>2020</year><volume>382</volume><fpage>727</fpage><lpage>733</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2001017</pub-id><?supplied-pmid 31978945?><pub-id pub-id-type="pmid">31978945</pub-id></element-citation></ref><ref id="B14-molecules-25-05905"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>A.</given-names></name><name><surname>Peng</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>B.</given-names></name><name><surname>Ding</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Niu</surname><given-names>P.</given-names></name><name><surname>Meng</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China</article-title><source>Cell Host Microbe</source><year>2020</year><volume>27</volume><fpage>325</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2020.02.001</pub-id><?supplied-pmid 32035028?><pub-id pub-id-type="pmid">32035028</pub-id></element-citation></ref><ref id="B15-molecules-25-05905"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>K.</given-names></name><name><surname>Guo</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Jiang</surname><given-names>C.</given-names></name></person-group><article-title>SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway</article-title><source>Cell Res.</source><year>2008</year><volume>18</volume><fpage>290</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1038/cr.2008.15</pub-id><?supplied-pmid 18227861?><pub-id pub-id-type="pmid">18227861</pub-id></element-citation></ref><ref id="B16-molecules-25-05905"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glowacka</surname><given-names>I.</given-names></name><name><surname>Bertram</surname><given-names>S.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>M.A.</given-names></name><name><surname>Allen</surname><given-names>P.D.</given-names></name><name><surname>Soilleux</surname><given-names>E.J.</given-names></name><name><surname>Pfefferle</surname><given-names>S.</given-names></name><name><surname>Steffen</surname><given-names>I.</given-names></name><name><surname>Tsegaye</surname><given-names>T.S.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Gnirss</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response</article-title><source>J. Virol.</source><year>2011</year><volume>85</volume><fpage>4122</fpage><lpage>4134</lpage><pub-id pub-id-type="doi">10.1128/JVI.02232-10</pub-id><?supplied-pmid 21325420?><pub-id pub-id-type="pmid">21325420</pub-id></element-citation></ref><ref id="B17-molecules-25-05905"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>J.</given-names></name><name><surname>Wan</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>C.</given-names></name><name><surname>Ye</surname><given-names>G.</given-names></name><name><surname>Geng</surname><given-names>Q.</given-names></name><name><surname>Auerbach</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name></person-group><article-title>Cell entry mechanisms of SARS-CoV-2</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2020</year><volume>117</volume><fpage>11727</fpage><lpage>11734</lpage><pub-id pub-id-type="doi">10.1073/pnas.2003138117</pub-id><pub-id pub-id-type="pmid">32376634</pub-id></element-citation></ref><ref id="B18-molecules-25-05905"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wrapp</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Corbett</surname><given-names>K.</given-names></name><name><surname>Goldsmith</surname><given-names>J.A.</given-names></name><name><surname>Hsieh</surname><given-names>C.-L.</given-names></name><name><surname>Abiona</surname><given-names>O.</given-names></name><name><surname>Graham</surname><given-names>B.S.</given-names></name><name><surname>McLellan</surname><given-names>J.S.</given-names></name></person-group><article-title>Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation</article-title><source>Science</source><year>2020</year><volume>367</volume><fpage>1260</fpage><lpage>1263</lpage><pub-id pub-id-type="doi">10.1126/science.abb2507</pub-id><pub-id pub-id-type="pmid">32075877</pub-id></element-citation></ref><ref id="B19-molecules-25-05905"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Ye</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name></person-group><article-title>Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence</article-title><source>Int J. Antimicrob Agents</source><year>2020</year><volume>55</volume><fpage>105948</fpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105948</pub-id><pub-id pub-id-type="pmid">32201353</pub-id></element-citation></ref><ref id="B20-molecules-25-05905"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Gou</surname><given-names>X.</given-names></name><name><surname>Pu</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Guo</surname><given-names>Q.</given-names></name><name><surname>Ji</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name></person-group><article-title>Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis</article-title><source>Int J. Infect Dis.</source><year>2020</year><volume>94</volume><fpage>91</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2020.03.017</pub-id><pub-id pub-id-type="pmid">32173574</pub-id></element-citation></ref><ref id="B21-molecules-25-05905"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>W.J.</given-names></name><name><surname>Ni</surname><given-names>Z.Y.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Liang</surname><given-names>W.H.</given-names></name><name><surname>Ou</surname><given-names>C.Q.</given-names></name><name><surname>He</surname><given-names>J.X.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Shan</surname><given-names>H.</given-names></name><name><surname>Lei</surname><given-names>C.L.</given-names></name><name><surname>Hui</surname><given-names>D.S.C.</given-names></name><etal/></person-group><article-title><italic>Clinical Characteristics of Coronavirus Disease</italic> 2019 in China</article-title><source>N Engl. J. Med.</source><year>2020</year><volume>382</volume><fpage>1708</fpage><lpage>1720</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2002032</pub-id><?supplied-pmid 32109013?><pub-id pub-id-type="pmid">32109013</pub-id></element-citation></ref><ref id="B22-molecules-25-05905"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>do Nascimento</surname><given-names>I.J.B.</given-names></name><name><surname>Cacic</surname><given-names>N.</given-names></name><name><surname>Abdulazeem</surname><given-names>H.M.</given-names></name><name><surname>Von Groote</surname><given-names>T.C.</given-names></name><name><surname>Jayarajah</surname><given-names>U.</given-names></name><name><surname>Weerasekara</surname><given-names>I.</given-names></name><name><surname>Esfahani</surname><given-names>M.A.</given-names></name><name><surname>Civile</surname><given-names>V.T.</given-names></name><name><surname>Marusic</surname><given-names>A.</given-names></name><name><surname>Jeron&#x0010d;i&#x00107;</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis</article-title><source>J. Clin. Med.</source><year>2020</year><volume>9</volume><elocation-id>941</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9040941</pub-id><?supplied-pmid 32235486?><pub-id pub-id-type="pmid">32235486</pub-id></element-citation></ref><ref id="B23-molecules-25-05905"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grasselli</surname><given-names>G.</given-names></name><name><surname>Zangrillo</surname><given-names>A.</given-names></name><name><surname>Zanella</surname><given-names>A.</given-names></name><name><surname>Antonelli</surname><given-names>M.</given-names></name><name><surname>Cabrini</surname><given-names>L.</given-names></name><name><surname>Castelli</surname><given-names>A.</given-names></name><name><surname>Cereda</surname><given-names>D.</given-names></name><name><surname>Coluccello</surname><given-names>A.</given-names></name><name><surname>Foti</surname><given-names>G.</given-names></name><name><surname>Fumagalli</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy</article-title><source>JAMA</source><year>2020</year><volume>323</volume><fpage>1574</fpage><lpage>1581</lpage><pub-id pub-id-type="doi">10.1001/jama.2020.5394</pub-id><?supplied-pmid 32250385?><pub-id pub-id-type="pmid">32250385</pub-id></element-citation></ref><ref id="B24-molecules-25-05905"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Ren</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Fan</surname><given-names>G.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Gu</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title><source>Lancet</source><year>2020</year><volume>395</volume><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id><pub-id pub-id-type="pmid">31986264</pub-id></element-citation></ref><ref id="B25-molecules-25-05905"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>N.</given-names></name><name><surname>Zhou</surname><given-names>M.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Qu</surname><given-names>J.</given-names></name><name><surname>Gong</surname><given-names>F.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name><name><surname>Qiu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study</article-title><source>Lancet</source><year>2020</year><volume>395</volume><fpage>507</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30211-7</pub-id><pub-id pub-id-type="pmid">32007143</pub-id></element-citation></ref><ref id="B26-molecules-25-05905"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name><name><surname>Jiang</surname><given-names>N.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Alwalid</surname><given-names>O.</given-names></name><name><surname>Gu</surname><given-names>J.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>C.</given-names></name></person-group><article-title>Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study</article-title><source>Lancet Infect Dis</source><year>2020</year><volume>20</volume><fpage>425</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30086-4</pub-id><pub-id pub-id-type="pmid">32105637</pub-id></element-citation></ref><ref id="B27-molecules-25-05905"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Hu</surname><given-names>B.</given-names></name><name><surname>Hu</surname><given-names>C.</given-names></name><name><surname>Zhu</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Xiang</surname><given-names>H.</given-names></name><name><surname>Cheng</surname><given-names>Z.</given-names></name><name><surname>Xiong</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus&#x02013;Infected Pneumonia in Wuhan, China</article-title><source>JAMA</source><year>2020</year><volume>323</volume><fpage>1061</fpage><pub-id pub-id-type="doi">10.1001/jama.2020.1585</pub-id><pub-id pub-id-type="pmid">32031570</pub-id></element-citation></ref><ref id="B28-molecules-25-05905"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>Q.</given-names></name></person-group><article-title>Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China</article-title><source>Liver Int.</source><year>2020</year><volume>40</volume><fpage>2095</fpage><lpage>2103</lpage><pub-id pub-id-type="doi">10.1111/liv.14455</pub-id><pub-id pub-id-type="pmid">32239796</pub-id></element-citation></ref><ref id="B29-molecules-25-05905"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhl&#x000e9;n</surname><given-names>M.</given-names></name><name><surname>Fagerberg</surname><given-names>L.</given-names></name><name><surname>Hallstr&#x000f6;m</surname><given-names>B.M.</given-names></name><name><surname>Lindskog</surname><given-names>C.</given-names></name><name><surname>Oksvold</surname><given-names>P.</given-names></name><name><surname>Mardinoglu</surname><given-names>A.</given-names></name><name><surname>Sivertsson</surname><given-names>&#x000c5;.</given-names></name><name><surname>Kampf</surname><given-names>C.</given-names></name><name><surname>Sj&#x000f6;stedt</surname><given-names>E.</given-names></name><name><surname>Asplund</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Tissue-based map of the human proteome</article-title><source>Science</source><year>2015</year><volume>347</volume><fpage>1260419</fpage><pub-id pub-id-type="doi">10.1126/science.1260419</pub-id><pub-id pub-id-type="pmid">25613900</pub-id></element-citation></ref><ref id="B30-molecules-25-05905"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Zhao</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Pathological findings of COVID-19 associated with acute respiratory distress syndrome</article-title><source>Lancet Respir. Med.</source><year>2020</year><volume>8</volume><fpage>420</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(20)30076-X</pub-id><pub-id pub-id-type="pmid">32085846</pub-id></element-citation></ref><ref id="B31-molecules-25-05905"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mallapaty</surname><given-names>S.</given-names></name></person-group><article-title>Why does the coronavirus spread so easily between people?</article-title><source>Nat. Cell Biol.</source><year>2020</year><volume>579</volume><fpage>183</fpage><pub-id pub-id-type="doi">10.1038/d41586-020-00660-x</pub-id><?supplied-pmid 32157230?><pub-id pub-id-type="pmid">32157230</pub-id></element-citation></ref><ref id="B32-molecules-25-05905"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>Q.</given-names></name><name><surname>Huang</surname><given-names>D.</given-names></name><name><surname>Ou</surname><given-names>P.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Xia</surname><given-names>Z.</given-names></name><name><surname>Su</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>COVID-19 in a designated infectious diseases hospital outside Hubei Province, China</article-title><source>Allergy</source><year>2020</year><volume>75</volume><fpage>1742</fpage><lpage>1752</lpage><pub-id pub-id-type="doi">10.1111/all.14309</pub-id><?supplied-pmid 32239761?><pub-id pub-id-type="pmid">32239761</pub-id></element-citation></ref><ref id="B33-molecules-25-05905"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Fan</surname><given-names>J.-G.</given-names></name></person-group><article-title>Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease</article-title><source>J. Clin. Transl. Hepatol.</source><year>2020</year><volume>8</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.14218/JCTH.2020.00019</pub-id><?supplied-pmid 32274341?><pub-id pub-id-type="pmid">32274339</pub-id></element-citation></ref><ref id="B34-molecules-25-05905"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diao</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Tan</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Ning</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><fpage>827</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2020.00827</pub-id><pub-id pub-id-type="pmid">32425950</pub-id></element-citation></ref><ref id="B35-molecules-25-05905"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>K.H.</given-names></name><name><surname>Tsang</surname><given-names>W.K.</given-names></name><name><surname>Tang</surname><given-names>C.S.</given-names></name><name><surname>Lam</surname><given-names>M.F.</given-names></name><name><surname>Lai</surname><given-names>F.M.</given-names></name><name><surname>To</surname><given-names>K.F.</given-names></name><name><surname>Fung</surname><given-names>K.S.</given-names></name><name><surname>Tang</surname><given-names>H.L.</given-names></name><name><surname>Yan</surname><given-names>W.W.</given-names></name><name><surname>Chan</surname><given-names>H.W.</given-names></name><etal/></person-group><article-title>Acute renal impairment in coronavirus-associated severe acute respiratory syndrome</article-title><source>Kidney Int.</source><year>2005</year><volume>67</volume><fpage>698</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1111/j.1523-1755.2005.67130.x</pub-id><pub-id pub-id-type="pmid">15673319</pub-id></element-citation></ref><ref id="B36-molecules-25-05905"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovalic</surname><given-names>A.J.</given-names></name><name><surname>Satapathy</surname><given-names>S.K.</given-names></name><name><surname>Thuluvath</surname><given-names>P.J.</given-names></name></person-group><article-title>Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: A systematic review and meta-analysis</article-title><source>Hepatol. Int.</source><year>2020</year><volume>14</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s12072-020-10078-2</pub-id><pub-id pub-id-type="pmid">31754958</pub-id></element-citation></ref><ref id="B37-molecules-25-05905"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lelubre</surname><given-names>C.</given-names></name><name><surname>Vincent</surname><given-names>J.-L.</given-names></name></person-group><article-title>Mechanisms and treatment of organ failure in sepsis</article-title><source>Nat. Rev. Nephrol.</source><year>2018</year><volume>14</volume><fpage>417</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1038/s41581-018-0005-7</pub-id><pub-id pub-id-type="pmid">29691495</pub-id></element-citation></ref><ref id="B38-molecules-25-05905"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strnad</surname><given-names>P.</given-names></name><name><surname>Tacke</surname><given-names>F.</given-names></name><name><surname>Koch</surname><given-names>A.</given-names></name><name><surname>Trautwein</surname><given-names>P.S.F.T.A.K.C.</given-names></name></person-group><article-title>Liver&#x02014;Guardian, modifier and target of sepsis</article-title><source>Nat. Rev. Gastroenterol. Hepatol.</source><year>2017</year><volume>14</volume><fpage>55</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1038/nrgastro.2016.168</pub-id><pub-id pub-id-type="pmid">27924081</pub-id></element-citation></ref><ref id="B39-molecules-25-05905"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joung</surname><given-names>J.-Y.</given-names></name><name><surname>Cho</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Choi</surname><given-names>S.</given-names></name><name><surname>Son</surname><given-names>C.-G.</given-names></name></person-group><article-title>A literature review for the mechanisms of stress-induced liver injury</article-title><source>Brain Behav.</source><year>2019</year><volume>9</volume><fpage>e01235</fpage><pub-id pub-id-type="doi">10.1002/brb3.1235</pub-id><pub-id pub-id-type="pmid">30761781</pub-id></element-citation></ref><ref id="B40-molecules-25-05905"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Cheng</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Tian</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Cheng</surname><given-names>J.</given-names></name></person-group><article-title>Clinical Features of COVID-19-Related Liver Functional Abnormality</article-title><source>Clin. Gastroenterol. Hepatol.</source><year>2020</year><volume>18</volume><fpage>1561</fpage><lpage>1566</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2020.04.002</pub-id><pub-id pub-id-type="pmid">32283325</pub-id></element-citation></ref><ref id="B41-molecules-25-05905"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>E.</given-names></name><name><surname>Babar</surname><given-names>A.</given-names></name><name><surname>Choudhary</surname><given-names>M.</given-names></name><name><surname>Kutner</surname><given-names>M.</given-names></name><name><surname>Pyrsopoulos</surname><given-names>N.</given-names></name></person-group><article-title>Acetaminophen-Induced Hepatotoxicity: A Comprehensive Update</article-title><source>J. Clin. Transl. Hepatol.</source><year>2016</year><volume>4</volume><fpage>131</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.14218/jcth.2015.00052</pub-id><?supplied-pmid 27350943?><pub-id pub-id-type="pmid">27350943</pub-id></element-citation></ref><ref id="B42-molecules-25-05905"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>R.</given-names></name><name><surname>Liang</surname><given-names>J.</given-names></name><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>L.-R.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>K.-C.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name></person-group><article-title>Implications of COVID-19 for patients with pre-existing digestive diseases</article-title><source>Lancet Gastroenterol. Hepatol.</source><year>2020</year><volume>5</volume><fpage>425</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1016/S2468-1253(20)30076-5</pub-id><pub-id pub-id-type="pmid">32171057</pub-id></element-citation></ref><ref id="B43-molecules-25-05905"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albillos</surname><given-names>A.</given-names></name><name><surname>Lario</surname><given-names>M.</given-names></name><name><surname>&#x000c1;lvarez-Mon</surname><given-names>M.</given-names></name></person-group><article-title>Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance</article-title><source>J. Hepatol.</source><year>2014</year><volume>61</volume><fpage>1385</fpage><lpage>1396</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2014.08.010</pub-id><?supplied-pmid 25135860?><pub-id pub-id-type="pmid">25135860</pub-id></element-citation></ref><ref id="B44-molecules-25-05905"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarin</surname><given-names>S.K.</given-names></name></person-group><article-title>&#x0201c;Fast, faster, and fastest: Science on the run during COVID-19 drama&#x0201d;&#x02014;&#x0201c;Do not forget the liver&#x0201d;</article-title><source>Hepatol. Int.</source><year>2020</year><volume>14</volume><fpage>454</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1007/s12072-020-10042-0</pub-id><pub-id pub-id-type="pmid">32277386</pub-id></element-citation></ref><ref id="B45-molecules-25-05905"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000fc;tte</surname><given-names>A.</given-names></name><name><surname>Ciesek</surname><given-names>S.</given-names></name><name><surname>Wedemeyer</surname><given-names>H.</given-names></name><name><surname>Anastasiou</surname><given-names>O.</given-names></name></person-group><article-title>Influenza virus infection as precipitating event of acute-on-chronic liver failure</article-title><source>J. Hepatol.</source><year>2019</year><volume>70</volume><fpage>797</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2018.11.015</pub-id><pub-id pub-id-type="pmid">30635243</pub-id></element-citation></ref><ref id="B46-molecules-25-05905"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>H.</given-names></name><name><surname>Wander</surname><given-names>P.</given-names></name><name><surname>Bernstein</surname><given-names>D.</given-names></name><name><surname>Satapathy</surname><given-names>S.K.</given-names></name></person-group><article-title>Acute on chronic liver failure from novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)</article-title><source>Liver International.</source><year>2020</year><volume>40</volume><fpage>1590</fpage><lpage>1593</lpage><pub-id pub-id-type="doi">10.1111/liv.14506</pub-id><pub-id pub-id-type="pmid">32369658</pub-id></element-citation></ref><ref id="B47-molecules-25-05905"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovalic</surname><given-names>A.J.</given-names></name><name><surname>Huang</surname><given-names>G.</given-names></name><name><surname>Thuluvath</surname><given-names>P.J.</given-names></name><name><surname>Satapathy</surname><given-names>S.K.</given-names></name></person-group><article-title>Elevated Liver Biochemistries in Hospitalized Chinese Patients with Severe COVID-19: Systematic Review and Meta-analysis</article-title><source>Hepatology</source><year>2020</year><pub-id pub-id-type="doi">10.1007/s12072-020-10078-2</pub-id></element-citation></ref><ref id="B48-molecules-25-05905"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>A.M.</given-names></name><name><surname>Kim</surname><given-names>W.R.</given-names></name><name><surname>Moriarty</surname><given-names>J.P.</given-names></name><name><surname>Shah</surname><given-names>N.D.</given-names></name><name><surname>Larson</surname><given-names>J.J.</given-names></name><name><surname>Kamath</surname><given-names>P.S.</given-names></name></person-group><article-title>Time trends in the health care burden and mortality of acute on chronic liver failure in the United States</article-title><source>Hepatology</source><year>2016</year><volume>64</volume><fpage>2165</fpage><lpage>2172</lpage><pub-id pub-id-type="doi">10.1002/hep.28812</pub-id><pub-id pub-id-type="pmid">27696493</pub-id></element-citation></ref><ref id="B49-molecules-25-05905"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sikander</surname><given-names>M.</given-names></name><name><surname>Malik</surname><given-names>S.</given-names></name><name><surname>Yadav</surname><given-names>D.</given-names></name><name><surname>Biswas</surname><given-names>S.</given-names></name><name><surname>Katare</surname><given-names>D.P.</given-names></name><name><surname>Jain</surname><given-names>S.K.</given-names></name></person-group><article-title>Cytoprotective activity of a trans-chalcone against hydrogen peroxide induced toxicity in hepatocellular carcinoma (HepG2) cells</article-title><source>Asian Pac. J. Cancer Prev.</source><year>2011</year><volume>12</volume><fpage>2513</fpage><lpage>2516</lpage><pub-id pub-id-type="pmid">22320949</pub-id></element-citation></ref><ref id="B50-molecules-25-05905"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sikander</surname><given-names>M.</given-names></name><name><surname>Malik</surname><given-names>S.</given-names></name><name><surname>Parveen</surname><given-names>K.</given-names></name><name><surname>Ahmad</surname><given-names>M.</given-names></name><name><surname>Yadav</surname><given-names>D.</given-names></name><name><surname>Bin Hafeez</surname><given-names>Z.</given-names></name><name><surname>Bansal</surname><given-names>M.</given-names></name></person-group><article-title>Hepatoprotective effect of Origanum vulgare in Wistar rats against carbon tetrachloride-induced hepatotoxicity</article-title><source>Protoplasma</source><year>2012</year><volume>250</volume><fpage>483</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1007/s00709-012-0431-5</pub-id><pub-id pub-id-type="pmid">22772591</pub-id></element-citation></ref><ref id="B51-molecules-25-05905"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>G.-F.</given-names></name><name><surname>Xu</surname><given-names>X.-R.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Gan</surname><given-names>R.-Y.</given-names></name><name><surname>Li</surname><given-names>H.-B.</given-names></name></person-group><article-title>Phenolic Compounds and Bioactivities of Pigmented Rice</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>2013</year><volume>53</volume><fpage>296</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1080/10408398.2010.529624</pub-id><?supplied-pmid 23216001?><pub-id pub-id-type="pmid">23216001</pub-id></element-citation></ref><ref id="B52-molecules-25-05905"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kempson</surname><given-names>S.A.</given-names></name><name><surname>Vovor-Dassu</surname><given-names>K.</given-names></name><name><surname>Day</surname><given-names>C.R.</given-names></name></person-group><article-title>Betaine Transport in Kidney and Liver: Use of Betaine in Liver Injury</article-title><source>Cell. Physiol. Biochem.</source><year>2013</year><volume>32</volume><fpage>32</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1159/000356622</pub-id><?supplied-pmid 24429813?><pub-id pub-id-type="pmid">24429813</pub-id></element-citation></ref><ref id="B53-molecules-25-05905"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Jiao</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name></person-group><article-title>Compositional characterisation of soluble apple polysaccharides, and their antioxidant and hepatoprotective effects on acute CCl4-caused liver damage in mice</article-title><source>Food Chem.</source><year>2013</year><volume>138</volume><fpage>1256</fpage><lpage>1264</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2012.10.030</pub-id><?supplied-pmid 23411241?><pub-id pub-id-type="pmid">23411241</pub-id></element-citation></ref><ref id="B54-molecules-25-05905"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saller</surname><given-names>R.</given-names></name><name><surname>Melzer</surname><given-names>J.</given-names></name><name><surname>Reichling</surname><given-names>J.</given-names></name><name><surname>Brignoli</surname><given-names>R.</given-names></name><name><surname>Meier</surname><given-names>R.</given-names></name></person-group><article-title>An Updated Systematic Review of the Pharmacology of Silymarin</article-title><source>Complement. Med. Res.</source><year>2007</year><volume>14</volume><fpage>70</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1159/000100581</pub-id><?supplied-pmid 17464157?><pub-id pub-id-type="pmid">17464157</pub-id></element-citation></ref><ref id="B55-molecules-25-05905"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barzaghi</surname><given-names>N.</given-names></name><name><surname>Crema</surname><given-names>F.</given-names></name><name><surname>Gatti</surname><given-names>G.</given-names></name><name><surname>Pifferi</surname><given-names>G.</given-names></name><name><surname>Perucca</surname><given-names>E.</given-names></name></person-group><article-title>Pharmacokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects</article-title><source>Eur. J. Drug Metab. Pharmacokinet.</source><year>1990</year><volume>15</volume><fpage>333</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1007/BF03190223</pub-id><?supplied-pmid 2088770?><pub-id pub-id-type="pmid">2088770</pub-id></element-citation></ref><ref id="B56-molecules-25-05905"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>M.</given-names></name><name><surname>Khan</surname><given-names>T.</given-names></name><name><surname>Fatima</surname><given-names>K.</given-names></name><name><surname>Ali</surname><given-names>Q.U.A.</given-names></name><name><surname>Ovais</surname><given-names>M.</given-names></name><name><surname>Khalil</surname><given-names>A.T.</given-names></name><name><surname>Ullah</surname><given-names>I.</given-names></name><name><surname>Raza</surname><given-names>A.</given-names></name><name><surname>Shinwari</surname><given-names>Z.K.</given-names></name><name><surname>Idrees</surname><given-names>M.</given-names></name></person-group><article-title>Selected hepatoprotective herbal medicines: Evidence from ethnomedicinal applications, animal models, and possible mechanism of actions</article-title><source>Phytotherapy Res.</source><year>2018</year><volume>32</volume><fpage>199</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1002/ptr.5957</pub-id></element-citation></ref><ref id="B57-molecules-25-05905"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Federico</surname><given-names>A.</given-names></name><name><surname>Dallio</surname><given-names>M.</given-names></name><name><surname>Loguercio</surname><given-names>C.</given-names></name></person-group><article-title>Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>191</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22020191</pub-id></element-citation></ref><ref id="B58-molecules-25-05905"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillessen</surname><given-names>A.</given-names></name><name><surname>Schmidt</surname><given-names>H.H.-J.</given-names></name></person-group><article-title>Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review</article-title><source>Adv. Ther.</source><year>2020</year><volume>37</volume><fpage>1279</fpage><lpage>1301</lpage><pub-id pub-id-type="doi">10.1007/s12325-020-01251-y</pub-id><pub-id pub-id-type="pmid">32065376</pub-id></element-citation></ref><ref id="B59-molecules-25-05905"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cacciapuoti</surname><given-names>F.</given-names></name><name><surname>Scognamiglio</surname><given-names>A.</given-names></name><name><surname>Palumbo</surname><given-names>R.</given-names></name><name><surname>Forte</surname><given-names>R.</given-names></name><name><surname>Cacciapuoti</surname><given-names>F.</given-names></name></person-group><article-title>Silymarin in non alcoholic fatty liver disease</article-title><source>World J. Hepatol.</source><year>2013</year><volume>5</volume><fpage>109</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.4254/wjh.v5.i3.109</pub-id><pub-id pub-id-type="pmid">23556042</pub-id></element-citation></ref><ref id="B60-molecules-25-05905"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freitag</surname><given-names>A.F.</given-names></name><name><surname>Cardia</surname><given-names>G.F.E.</given-names></name><name><surname>Da Rocha</surname><given-names>B.A.</given-names></name><name><surname>Aguiar</surname><given-names>R.P.</given-names></name><name><surname>Silva-Comar</surname><given-names>F.M.D.S.</given-names></name><name><surname>Spironello</surname><given-names>R.A.</given-names></name><name><surname>Grespan</surname><given-names>R.</given-names></name><name><surname>Caparroz-Assef</surname><given-names>S.M.</given-names></name><name><surname>Bersani-Amado</surname><given-names>C.A.</given-names></name><name><surname>Cuman</surname><given-names>R.K.N.</given-names></name></person-group><article-title>Hepatoprotective Effect of Silymarin (Silybum marianum) on Hepatotoxicity Induced by Acetaminophen in Spontaneously Hypertensive Rats</article-title><source>Evidence-Based Complement. Altern. Med.</source><year>2015</year><volume>2015</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1155/2015/538317</pub-id></element-citation></ref><ref id="B61-molecules-25-05905"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>C.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name></person-group><article-title>Synchronized and sustained release of multiple components in silymarin from erodible glyceryl monostearate matrix system</article-title><source>Eur. J. Pharm. Biopharm.</source><year>2007</year><volume>66</volume><fpage>210</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2006.11.008</pub-id><?supplied-pmid 17196805?><pub-id pub-id-type="pmid">17196805</pub-id></element-citation></ref><ref id="B62-molecules-25-05905"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valenzuela</surname><given-names>A.</given-names></name><name><surname>Guerra</surname><given-names>R.</given-names></name><name><surname>Garrido</surname><given-names>A.</given-names></name></person-group><article-title>Silybin Dihemisuccinate Protects Rat Erythrocytes Against Phenylhydrazine-Induced Lipid Peroxidation and Hemolysis</article-title><source>Planta Medica</source><year>2007</year><volume>53</volume><fpage>402</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1055/s-2006-962757</pub-id><?supplied-pmid 3432421?><pub-id pub-id-type="pmid">3432421</pub-id></element-citation></ref><ref id="B63-molecules-25-05905"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nencini</surname><given-names>C.</given-names></name><name><surname>Giorgi</surname><given-names>G.</given-names></name><name><surname>Micheli</surname><given-names>L.</given-names></name></person-group><article-title>Protective effect of silymarin on oxidative stress in rat brain</article-title><source>Phytomedicine</source><year>2007</year><volume>14</volume><fpage>129</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2006.02.005</pub-id><?supplied-pmid 16638633?><pub-id pub-id-type="pmid">16638633</pub-id></element-citation></ref><ref id="B64-molecules-25-05905"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Federico</surname><given-names>A.</given-names></name><name><surname>Dallio</surname><given-names>M.</given-names></name><name><surname>Di Fabio</surname><given-names>G.</given-names></name><name><surname>Zarrelli</surname><given-names>A.</given-names></name><name><surname>Zappavigna</surname><given-names>S.</given-names></name><name><surname>Stiuso</surname><given-names>P.</given-names></name><name><surname>Tuccillo</surname><given-names>C.</given-names></name><name><surname>Caraglia</surname><given-names>M.</given-names></name><name><surname>Loguercio</surname><given-names>C.</given-names></name></person-group><article-title>Silybin-Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress</article-title><source>Vivo</source><year>2015</year><volume>29</volume><fpage>569</fpage><lpage>575</lpage></element-citation></ref><ref id="B65-molecules-25-05905"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas-Mendoza</surname><given-names>N.</given-names></name><name><surname>Madrigal-Santill&#x000e1;n</surname><given-names>E.</given-names></name><name><surname>Morales-Gonz&#x000e1;lez</surname><given-names>A.</given-names></name><name><surname>Esquivel-Soto</surname><given-names>J.</given-names></name><name><surname>Esquivel-Chirino</surname><given-names>C.</given-names></name><name><surname>Garc&#x000ed;a-Luna</surname><given-names>Y.G.-R.M.</given-names></name><name><surname>Gayosso-de-Lucio</surname><given-names>J.A.</given-names></name><name><surname>Morales-Gonz&#x000e1;lez</surname><given-names>J.A.</given-names></name></person-group><article-title>Hepatoprotective effect of silymarin</article-title><source>World J. Hepatol.</source><year>2014</year><volume>6</volume><fpage>144</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.4254/wjh.v6.i3.144</pub-id><pub-id pub-id-type="pmid">24672644</pub-id></element-citation></ref><ref id="B66-molecules-25-05905"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molt&#x000f3;</surname><given-names>J.</given-names></name><name><surname>Valle</surname><given-names>M.</given-names></name><name><surname>Miranda</surname><given-names>C.</given-names></name><name><surname>Cede&#x000f1;o</surname><given-names>S.</given-names></name><name><surname>Negredo</surname><given-names>E.</given-names></name><name><surname>Clotet</surname><given-names>B.</given-names></name></person-group><article-title>Effect of Milk Thistle on the Pharmacokinetics of Darunavir-Ritonavir in HIV-Infected Patients</article-title><source>Antimicrob. Agents Chemother.</source><year>2012</year><volume>56</volume><fpage>2837</fpage><lpage>2841</lpage><pub-id pub-id-type="doi">10.1128/AAC.00025-12</pub-id><pub-id pub-id-type="pmid">22430963</pub-id></element-citation></ref><ref id="B67-molecules-25-05905"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosch-Barrera</surname><given-names>J.</given-names></name><name><surname>Martin-Castillo</surname><given-names>B.</given-names></name><name><surname>Bux&#x000f3;</surname><given-names>M.</given-names></name><name><surname>Brunet</surname><given-names>J.</given-names></name><name><surname>Encinar</surname><given-names>J.A.</given-names></name><name><surname>Menendez</surname><given-names>J.A.</given-names></name></person-group><article-title>Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients</article-title><source>J. Clin. Med.</source><year>2020</year><volume>9</volume><elocation-id>1770</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9061770</pub-id></element-citation></ref><ref id="B68-molecules-25-05905"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferenci</surname><given-names>P.</given-names></name><name><surname>Scherzer</surname><given-names>T.</given-names></name><name><surname>Kerschner</surname><given-names>H.</given-names></name><name><surname>Rutter</surname><given-names>K.</given-names></name><name><surname>Beinhardt</surname><given-names>S.</given-names></name><name><surname>Hofer</surname><given-names>H.</given-names></name><name><surname>Sch&#x000f6;niger&#x02013;Hekele</surname><given-names>M.</given-names></name><name><surname>Holzmann</surname><given-names>H.</given-names></name><name><surname>Steindl-Munda</surname><given-names>P.</given-names></name></person-group><article-title>Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy</article-title><source>Gastroenterology</source><year>2008</year><volume>135</volume><fpage>1561</fpage><lpage>1567</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2008.07.072</pub-id><pub-id pub-id-type="pmid">18771667</pub-id></element-citation></ref><ref id="B69-molecules-25-05905"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jimoh</surname><given-names>F.</given-names></name><name><surname>Adedapo</surname><given-names>A.A.</given-names></name><name><surname>Afolayan</surname><given-names>A.</given-names></name></person-group><article-title>Comparison of the nutritional value and biological activities of the acetone, methanol and water extracts of the leaves of Solanum nigrum and Leonotis leonorus</article-title><source>Food Chem. Toxicol.</source><year>2010</year><volume>48</volume><fpage>964</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2010.01.007</pub-id><pub-id pub-id-type="pmid">20079394</pub-id></element-citation></ref><ref id="B70-molecules-25-05905"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Feng</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name></person-group><article-title>Aqueous extract of Solanum nigrum inhibit growth of cervical carcinoma (U14) via modulating immune response of tumor bearing mice and inducing apoptosis of tumor cells</article-title><source>Fitoterapia</source><year>2008</year><volume>79</volume><fpage>548</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2008.06.010</pub-id><pub-id pub-id-type="pmid">18687388</pub-id></element-citation></ref><ref id="B71-molecules-25-05905"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>M.-M.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Han</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>C.-W.</given-names></name><name><surname>Chang</surname><given-names>Y.-C.</given-names></name><name><surname>Zhao</surname><given-names>C.-W.</given-names></name><name><surname>Lin</surname><given-names>Y.-X.</given-names></name></person-group><article-title>Hepatoprotective effects of Solanum nigrum against ethanol-induced injury in primary hepatocytes and mice with analysis of glutathione S-transferase A1</article-title><source>J. Chin. Med Assoc.</source><year>2016</year><volume>79</volume><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.jcma.2015.08.013</pub-id><?supplied-pmid 26775601?><pub-id pub-id-type="pmid">26775601</pub-id></element-citation></ref><ref id="B72-molecules-25-05905"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campisi</surname><given-names>A.</given-names></name><name><surname>Acquaviva</surname><given-names>R.</given-names></name><name><surname>Raciti</surname><given-names>G.</given-names></name><name><surname>Duro</surname><given-names>A.</given-names></name><name><surname>Rizzo</surname><given-names>M.</given-names></name><name><surname>Santagati</surname><given-names>N.A.</given-names></name></person-group><article-title>Antioxidant Activities of Solanum Nigrum L. Leaf Extracts Determined in in vitro Cellular Models</article-title><source>Foods</source><year>2019</year><volume>8</volume><elocation-id>63</elocation-id><pub-id pub-id-type="doi">10.3390/foods8020063</pub-id><?supplied-pmid 30744041?><pub-id pub-id-type="pmid">30744041</pub-id></element-citation></ref><ref id="B73-molecules-25-05905"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucia</surname><given-names>L.M.</given-names></name><name><surname>Ghedira</surname><given-names>K.</given-names></name></person-group><article-title>Comparative analysis of medicinal plants used in traditional medicine in Italy and Tunisia</article-title><source>J. Ethnobiol. Ethnomedicine</source><year>2009</year><volume>5</volume><fpage>31</fpage><pub-id pub-id-type="doi">10.1186/1746-4269-5-31</pub-id></element-citation></ref><ref id="B74-molecules-25-05905"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>R.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Gupta</surname><given-names>S.</given-names></name><name><surname>Sarethy</surname><given-names>I.P.</given-names></name><name><surname>Gabrani</surname><given-names>R.</given-names></name></person-group><article-title>Solanum nigrum: Current perspectives on therapeutic properties</article-title><source>Altern. Med. Rev.</source><year>2011</year><volume>16</volume><fpage>78</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">21438649</pub-id></element-citation></ref><ref id="B75-molecules-25-05905"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Ji</surname><given-names>Y.</given-names></name><name><surname>An</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name></person-group><article-title>Traditional Herbal Medicine: A Review of Potential of Inhibitory Hepatocellular Carcinoma in Basic Research and Clinical Trial</article-title><source>Evidence-Based Complement. Altern. Med.</source><year>2013</year><volume>2013</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1155/2013/268963</pub-id></element-citation></ref><ref id="B76-molecules-25-05905"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H.-C.</given-names></name><name><surname>Syu</surname><given-names>K.-Y.</given-names></name><name><surname>Lin</surname><given-names>J.-K.</given-names></name></person-group><article-title>Chemical Composition of Solanum nigrum Linn Extract and Induction of Autophagy by Leaf Water Extract and Its Major Flavonoids in AU565 Breast Cancer Cells</article-title><source>J. Agric. Food Chem.</source><year>2010</year><volume>58</volume><fpage>8699</fpage><lpage>8708</lpage><pub-id pub-id-type="doi">10.1021/jf101003v</pub-id><pub-id pub-id-type="pmid">20681660</pub-id></element-citation></ref><ref id="B77-molecules-25-05905"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petruzziello</surname><given-names>A.</given-names></name><name><surname>Marigliano</surname><given-names>S.</given-names></name><name><surname>Loquercio</surname><given-names>G.</given-names></name><name><surname>Cacciapuoti</surname><given-names>C.</given-names></name></person-group><article-title>Hepatitis C virus (HCV) genotypes distribution: An epidemiological up-date in Europe</article-title><source>Infect. Agents Cancer</source><year>2016</year><volume>11</volume><fpage>53</fpage><pub-id pub-id-type="doi">10.1186/s13027-016-0099-0</pub-id></element-citation></ref><ref id="B78-molecules-25-05905"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sultana</surname><given-names>S.</given-names></name><name><surname>Perwaiz</surname><given-names>S.</given-names></name><name><surname>Iqbal</surname><given-names>M.</given-names></name><name><surname>Athar</surname><given-names>M.</given-names></name></person-group><article-title>Crude extracts of hepatoprotective plants, Solanum nigrum and Cichorium intybus inhibit free radical-mediated DNA damage</article-title><source>J. Ethnopharmacol.</source><year>1995</year><volume>45</volume><fpage>189</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/0378-8741(94)01214-K</pub-id><pub-id pub-id-type="pmid">7623482</pub-id></element-citation></ref><ref id="B79-molecules-25-05905"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H.M.</given-names></name><name><surname>Tseng</surname><given-names>H.C.</given-names></name><name><surname>Wang</surname><given-names>C.J.</given-names></name><name><surname>Lin</surname><given-names>J.J.</given-names></name><name><surname>Lo</surname><given-names>C.W.</given-names></name><name><surname>Chou</surname><given-names>F.P.</given-names></name></person-group><article-title>Hepatoprotective effects of Solanum nigrum Linn extract against CCl(4)-induced oxidative damage in rats</article-title><source>Chem Biol Interact</source><year>2008</year><volume>171</volume><fpage>283</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2007.08.008</pub-id><pub-id pub-id-type="pmid">18045581</pub-id></element-citation></ref><ref id="B80-molecules-25-05905"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upadhyay</surname><given-names>P.</given-names></name><name><surname>Ara</surname><given-names>S.</given-names></name><name><surname>Prakash</surname><given-names>P.</given-names></name></person-group><article-title>Antibacterial and Antioxidant Activity of Solanum nigrum Stem and Leaves</article-title><source>Chem. Sci. Trans.</source><year>2015</year><volume>4</volume><fpage>1013</fpage><lpage>1017</lpage><pub-id pub-id-type="doi">10.7598/cst2015.1097</pub-id></element-citation></ref><ref id="B81-molecules-25-05905"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>N&#x000f8;rbaek</surname><given-names>R.</given-names></name><name><surname>Nielsen</surname><given-names>K.</given-names></name><name><surname>Kondo</surname><given-names>T.</given-names></name></person-group><article-title>Anthocyanins from flowers of Cichorium intybus</article-title><source>Phytochemistry</source><year>2002</year><volume>60</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">12031425</pub-id></element-citation></ref><ref id="B82-molecules-25-05905"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mares</surname><given-names>D.</given-names></name><name><surname>Romagnoli</surname><given-names>C.</given-names></name><name><surname>Tosi</surname><given-names>B.</given-names></name><name><surname>Andreotti</surname><given-names>E.</given-names></name><name><surname>Chillemi</surname><given-names>G.</given-names></name><name><surname>Poli</surname><given-names>F.</given-names></name></person-group><article-title>Chicory extracts from Cichorium intybus L. as potential antifungals</article-title><source>Mycopathologia</source><year>2005</year><volume>160</volume><fpage>85</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1007/s11046-004-6635-2</pub-id><?supplied-pmid 16160773?><pub-id pub-id-type="pmid">16160773</pub-id></element-citation></ref><ref id="B83-molecules-25-05905"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Cui</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Cui</surname><given-names>J.</given-names></name></person-group><article-title>Antimicrobial and Antioxidant Activities ofCichorium IntybusRoot Extract Using Orthogonal Matrix Design</article-title><source>J. Food Sci.</source><year>2013</year><volume>78</volume><fpage>M258</fpage><lpage>M263</lpage><pub-id pub-id-type="doi">10.1111/1750-3841.12040</pub-id><?supplied-pmid 23387896?><pub-id pub-id-type="pmid">23387896</pub-id></element-citation></ref><ref id="B84-molecules-25-05905"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.-H.</given-names></name><name><surname>Mun</surname><given-names>Y.-J.</given-names></name><name><surname>Woo</surname><given-names>W.-H.</given-names></name><name><surname>Jeon</surname><given-names>K.-S.</given-names></name><name><surname>An</surname><given-names>N.-H.</given-names></name><name><surname>Park</surname><given-names>J.-S.</given-names></name></person-group><article-title>Effects of the ethanol extract of Cichorium intybus on the immunotoxicity by ethanol in mice</article-title><source>Int. Immunopharmacol.</source><year>2002</year><volume>2</volume><fpage>733</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1016/S1567-5769(02)00008-5</pub-id><pub-id pub-id-type="pmid">12095163</pub-id></element-citation></ref><ref id="B85-molecules-25-05905"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilani</surname><given-names>A.-H.</given-names></name><name><surname>Janbaz</surname><given-names>K.</given-names></name></person-group><article-title>Evaluation of the liver protective potential of Cichorium intybus seed extract on Acetaminophen and CCl4-induced damage</article-title><source>Phytomedicine</source><year>1994</year><volume>1</volume><fpage>193</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/S0944-7113(11)80064-4</pub-id><pub-id pub-id-type="pmid">23195938</pub-id></element-citation></ref><ref id="B86-molecules-25-05905"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>H.A.</given-names></name><name><surname>Yousef</surname><given-names>M.I.</given-names></name></person-group><article-title>Ameliorating effect of chicory (Cichorium intybus L.)-supplemented diet against nitrosamine precursors-induced liver injury and oxidative stress in male rats</article-title><source>Food Chem. Toxicol.</source><year>2010</year><volume>48</volume><fpage>2163</fpage><lpage>2169</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2010.05.023</pub-id><?supplied-pmid 20478349?><pub-id pub-id-type="pmid">20478349</pub-id></element-citation></ref><ref id="B87-molecules-25-05905"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>B.</given-names></name><name><surname>Al-Howiriny</surname><given-names>T.A.</given-names></name><name><surname>Siddiqui</surname><given-names>A.B.</given-names></name></person-group><article-title>Antihepatotoxic activity of seeds of Cichorium intybus</article-title><source>J. Ethnopharmacol.</source><year>2003</year><volume>87</volume><fpage>237</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(03)00145-4</pub-id><pub-id pub-id-type="pmid">12860315</pub-id></element-citation></ref><ref id="B88-molecules-25-05905"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azay-Milhau</surname><given-names>J.</given-names></name><name><surname>Ferrare</surname><given-names>K.</given-names></name><name><surname>Leroy</surname><given-names>J.</given-names></name><name><surname>Aubaterre</surname><given-names>J.</given-names></name><name><surname>Tournier</surname><given-names>M.</given-names></name><name><surname>Lajoix</surname><given-names>A.-D.</given-names></name><name><surname>Tousch</surname><given-names>D.</given-names></name></person-group><article-title>Antihyperglycemic effect of a natural chicoric acid extract of chicory (Cichorium intybus L.): A comparative in vitro study with the effects of caffeic and ferulic acids</article-title><source>J. Ethnopharmacol.</source><year>2013</year><volume>150</volume><fpage>755</fpage><lpage>760</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2013.09.046</pub-id><pub-id pub-id-type="pmid">24126061</pub-id></element-citation></ref><ref id="B89-molecules-25-05905"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>T.-W.</given-names></name><name><surname>Yang</surname><given-names>K.-S.</given-names></name></person-group><article-title>Antioxidative effects of cichorium intybus root extract on LDL (low density lipoprotein) oxidation</article-title><source>Arch. Pharmacal Res.</source><year>2001</year><volume>24</volume><fpage>431</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1007/BF02975190</pub-id></element-citation></ref><ref id="B90-molecules-25-05905"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Street</surname><given-names>R.A.</given-names></name><name><surname>Sidana</surname><given-names>J.</given-names></name><name><surname>Prinsloo</surname><given-names>G.</given-names></name></person-group><article-title>Cichorium intybus: Traditional Uses, Phytochemistry, Pharmacology, and Toxicology</article-title><source>Evidence-Based Complement. Altern. Med.</source><year>2013</year><volume>2013</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1155/2013/579319</pub-id></element-citation></ref><ref id="B91-molecules-25-05905"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elgengaihi</surname><given-names>S.</given-names></name><name><surname>Mossa</surname><given-names>A.-T.H.</given-names></name><name><surname>Refaie</surname><given-names>A.A.E.-R.</given-names></name><name><surname>Aboubaker</surname><given-names>D.</given-names></name></person-group><article-title>Hepatoprotective Efficacy ofCichorium intybusL. Extract Against Carbon Tetrachloride-induced Liver Damage in Rats</article-title><source>J. Diet. Suppl.</source><year>2016</year><volume>13</volume><fpage>570</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.3109/19390211.2016.1144230</pub-id><?supplied-pmid 26913368?><pub-id pub-id-type="pmid">26913368</pub-id></element-citation></ref><ref id="B92-molecules-25-05905"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.-L.</given-names></name><name><surname>Dai</surname><given-names>L.-H.</given-names></name><name><surname>Wu</surname><given-names>Y.-H.</given-names></name><name><surname>Yu</surname><given-names>X.-P.</given-names></name><name><surname>Zhang</surname><given-names>Y.-Y.</given-names></name><name><surname>Guan</surname><given-names>R.-F.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name></person-group><article-title>Evaluation of Hepatocyteprotective and Anti-hepatitis B Virus Properties of Cichoric Acid from Cichorium intybus Leaves in Cell Culture</article-title><source>Biol. Pharm. Bull.</source><year>2014</year><volume>37</volume><fpage>1214</fpage><lpage>1220</lpage><pub-id pub-id-type="doi">10.1248/bpb.b14-00137</pub-id><?supplied-pmid 24759764?><pub-id pub-id-type="pmid">24759764</pub-id></element-citation></ref><ref id="B93-molecules-25-05905"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vimal</surname><given-names>V.</given-names></name><name><surname>Devaki</surname><given-names>T.</given-names></name></person-group><article-title>Hepatoprotective effect of allicin on tissue defense system in galactosamine/endotoxin challenged rats</article-title><source>J. Ethnopharmacol.</source><year>2004</year><volume>90</volume><fpage>151</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2003.09.027</pub-id><?supplied-pmid 14698523?><pub-id pub-id-type="pmid">14698523</pub-id></element-citation></ref><ref id="B94-molecules-25-05905"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>J.</given-names></name><name><surname>Liong</surname><given-names>E.C.</given-names></name><name><surname>Ling</surname><given-names>M.-T.</given-names></name><name><surname>Ching</surname><given-names>Y.-P.</given-names></name><name><surname>Fung</surname><given-names>M.-L.</given-names></name><name><surname>Tipoe</surname><given-names>G.L.</given-names></name></person-group><article-title>S-allylmercaptocysteine reduces carbon tetrachloride-induced hepatic oxidative stress and necroinflammation via nuclear factor kappa B-dependent pathways in mice</article-title><source>Eur. J. Nutr.</source><year>2012</year><volume>51</volume><fpage>323</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1007/s00394-011-0217-0</pub-id><pub-id pub-id-type="pmid">21681437</pub-id></element-citation></ref><ref id="B95-molecules-25-05905"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>J.H.</given-names></name><name><surname>Lee</surname><given-names>C.W.</given-names></name><name><surname>Oh</surname><given-names>S.J.</given-names></name><name><surname>Yun</surname><given-names>J.</given-names></name><name><surname>Kang</surname><given-names>M.R.</given-names></name><name><surname>Han</surname><given-names>S.-B.</given-names></name><name><surname>Park</surname><given-names>H.</given-names></name><name><surname>Jung</surname><given-names>J.C.</given-names></name><name><surname>Chung</surname><given-names>Y.H.</given-names></name><name><surname>Kang</surname><given-names>J.S.</given-names></name></person-group><article-title>Hepatoprotective Effect of Aged Black Garlic Extract in Rodents</article-title><source>Toxicol. Res.</source><year>2014</year><volume>30</volume><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.5487/TR.2014.30.1.049</pub-id><pub-id pub-id-type="pmid">24795800</pub-id></element-citation></ref><ref id="B96-molecules-25-05905"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meghwal</surname><given-names>M.</given-names></name></person-group><article-title>A Review on the Functional Properties, Nutritional Content, Medicinal Utilization and Potential Application of Fenugreek</article-title><source>J. Food Process. Technol.</source><year>2012</year><volume>3</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.4172/2157-7110.1000181</pub-id></element-citation></ref><ref id="B97-molecules-25-05905"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bongiorno</surname><given-names>P.B.</given-names></name><name><surname>Fratellone</surname><given-names>P.M.</given-names></name><name><surname>Logiudice</surname><given-names>P.</given-names></name></person-group><article-title>Potential Health Benefits of Garlic (Allium Sativum): A Narrative Review</article-title><source>J. Complement. Integr. Med.</source><year>2008</year><volume>5</volume><fpage>5</fpage><pub-id pub-id-type="doi">10.2202/1553-3840.1084</pub-id></element-citation></ref><ref id="B98-molecules-25-05905"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C.-H.</given-names></name><name><surname>Park</surname><given-names>S.-W.</given-names></name><name><surname>Kim</surname><given-names>Y.S.</given-names></name><name><surname>Kang</surname><given-names>S.S.</given-names></name><name><surname>Kim</surname><given-names>J.A.</given-names></name><name><surname>Lee</surname><given-names>S.H.</given-names></name><name><surname>Lee</surname><given-names>S.-M.</given-names></name></person-group><article-title>Protective Mechanism of Glycyrrhizin on Acute Liver Injury Induced by Carbon Tetrachloride in Mice</article-title><source>Biol. Pharm. Bull.</source><year>2007</year><volume>30</volume><fpage>1898</fpage><lpage>1904</lpage><pub-id pub-id-type="doi">10.1248/bpb.30.1898</pub-id><pub-id pub-id-type="pmid">17917259</pub-id></element-citation></ref><ref id="B99-molecules-25-05905"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>M.</given-names></name><name><surname>Moro</surname><given-names>T.</given-names></name><name><surname>Motegi</surname><given-names>H.</given-names></name><name><surname>Maruyama</surname><given-names>H.</given-names></name><name><surname>Sekine</surname><given-names>M.</given-names></name><name><surname>Okamoto</surname><given-names>H.</given-names></name><name><surname>Inoue</surname><given-names>H.</given-names></name><name><surname>Sato</surname><given-names>T.</given-names></name><name><surname>Ogihara</surname><given-names>M.</given-names></name></person-group><article-title>In vivo glycyrrhizin accelerates liver regeneration and rapidly lowers serum transaminase activities in 70% partially hepatectomized rats</article-title><source>Eur. J. Pharmacol.</source><year>2008</year><volume>579</volume><fpage>357</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2007.10.073</pub-id><pub-id pub-id-type="pmid">18022618</pub-id></element-citation></ref><ref id="B100-molecules-25-05905"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pastorino</surname><given-names>G.</given-names></name><name><surname>Cornara</surname><given-names>L.</given-names></name><name><surname>Soares</surname><given-names>S.</given-names></name><name><surname>Rodrigues</surname><given-names>F.</given-names></name><name><surname>Oliveira</surname><given-names>M.B.P.P.</given-names></name></person-group><article-title>Liquorice (<italic>Glycyrrhiza glabra</italic>): A phytochemical and pharmacological review</article-title><source>Phytotherapy Res.</source><year>2018</year><volume>32</volume><fpage>2323</fpage><lpage>2339</lpage><pub-id pub-id-type="doi">10.1002/ptr.6178</pub-id></element-citation></ref><ref id="B101-molecules-25-05905"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Tan</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Zou</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>A Comprehensive Review for Phytochemical, Pharmacological, and Biosynthesis Studies on Glycyrrhiza spp</article-title><source>Am. J. Chin. Med.</source><year>2020</year><volume>48</volume><fpage>17</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1142/S0192415X20500020</pub-id><?supplied-pmid 31931596?><pub-id pub-id-type="pmid">31931596</pub-id></element-citation></ref><ref id="B102-molecules-25-05905"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseinzadeh</surname><given-names>H.</given-names></name><name><surname>Nassiri-Asl</surname><given-names>M.</given-names></name></person-group><article-title>Pharmacological Effects of Glycyrrhiza spp. and Its Bioactive Constituents: Update and Review</article-title><source>Phytotherapy Res.</source><year>2015</year><volume>29</volume><fpage>1868</fpage><lpage>1886</lpage><pub-id pub-id-type="doi">10.1002/ptr.5487</pub-id><?supplied-pmid 26462981?><pub-id pub-id-type="pmid">26462981</pub-id></element-citation></ref><ref id="B103-molecules-25-05905"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashfaq</surname><given-names>U.A.</given-names></name><name><surname>Masoud</surname><given-names>M.S.</given-names></name><name><surname>Nawaz</surname><given-names>Z.</given-names></name><name><surname>Riazuddin</surname><given-names>S.</given-names></name></person-group><article-title>Glycyrrhizin as antiviral agent against Hepatitis C Virus</article-title><source>J. Transl. Med.</source><year>2011</year><volume>9</volume><fpage>112</fpage><pub-id pub-id-type="doi">10.1186/1479-5876-9-112</pub-id><?supplied-pmid 21762538?><pub-id pub-id-type="pmid">21762538</pub-id></element-citation></ref><ref id="B104-molecules-25-05905"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname><given-names>M.</given-names></name><name><surname>Shigeta</surname><given-names>S.</given-names></name></person-group><article-title>Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro</article-title><source>Antivir. Res.</source><year>1987</year><volume>7</volume><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/0166-3542(87)90025-8</pub-id><pub-id pub-id-type="pmid">3034150</pub-id></element-citation></ref><ref id="B105-molecules-25-05905"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baltina</surname><given-names>L.A.</given-names></name><name><surname>Tasi</surname><given-names>Y.-T.</given-names></name><name><surname>Huang</surname><given-names>S.-H.</given-names></name><name><surname>Lai</surname><given-names>H.-C.</given-names></name><name><surname>Petrova</surname><given-names>S.F.</given-names></name><name><surname>Yunusov</surname><given-names>M.S.</given-names></name><name><surname>Lin</surname><given-names>C.-W.</given-names></name></person-group><article-title>Glycyrrhizic acid derivatives as Dengue virus inhibitors</article-title><source>Bioorganic Med. Chem. Lett.</source><year>2019</year><volume>29</volume><fpage>126645</fpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2019.126645</pub-id><?supplied-pmid 31519375?><pub-id pub-id-type="pmid">31519375</pub-id></element-citation></ref><ref id="B106-molecules-25-05905"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bentz</surname><given-names>G.L.</given-names></name><name><surname>Lowrey</surname><given-names>A.J.</given-names></name><name><surname>Horne</surname><given-names>D.C.</given-names></name><name><surname>Nguyen</surname><given-names>V.</given-names></name><name><surname>Satterfield</surname><given-names>A.R.</given-names></name><name><surname>Ross</surname><given-names>T.D.</given-names></name><name><surname>Harrod</surname><given-names>A.E.</given-names></name><name><surname>Uchakina</surname><given-names>O.N.</given-names></name><name><surname>McKallip</surname><given-names>R.J.</given-names></name></person-group><article-title>Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency</article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><elocation-id>e0217578</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0217578</pub-id><pub-id pub-id-type="pmid">31125383</pub-id></element-citation></ref><ref id="B107-molecules-25-05905"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Briolant</surname><given-names>S.</given-names></name><name><surname>Garin</surname><given-names>D.</given-names></name><name><surname>Scaramozzino</surname><given-names>N.</given-names></name><name><surname>Jouan</surname><given-names>A.</given-names></name><name><surname>Crance</surname><given-names>J.</given-names></name></person-group><article-title>In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: Synergistic effect of interferon-&#x003b1; and ribavirin combination</article-title><source>Antivir. Res.</source><year>2004</year><volume>61</volume><fpage>111</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2003.09.005</pub-id><pub-id pub-id-type="pmid">14670584</pub-id></element-citation></ref><ref id="B108-molecules-25-05905"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crance</surname><given-names>J.-M.</given-names></name><name><surname>L&#x000e9;v&#x000e8;que</surname><given-names>F.</given-names></name><name><surname>Biziagos</surname><given-names>E.</given-names></name><name><surname>Van Cuyck-Gandr&#x000e9;</surname><given-names>H.</given-names></name><name><surname>Jouan</surname><given-names>A.</given-names></name><name><surname>Deloince</surname><given-names>R.</given-names></name></person-group><article-title>Studies on mechanism of action of glycyrrhizin against hepatitis a virus replication in vitro</article-title><source>Antivir. Res.</source><year>1994</year><volume>23</volume><fpage>63</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/0166-3542(94)90033-7</pub-id><pub-id pub-id-type="pmid">8141593</pub-id></element-citation></ref><ref id="B109-molecules-25-05905"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crance</surname><given-names>J.M.</given-names></name><name><surname>Biziagos</surname><given-names>E.</given-names></name><name><surname>Passagot</surname><given-names>J.</given-names></name><name><surname>Van Cuyck-Gandr&#x000e9;</surname><given-names>H.</given-names></name><name><surname>Deloince</surname><given-names>R.</given-names></name></person-group><article-title>Inhibition of hepatitis A virus replication in vitro by antiviral compounds</article-title><source>J. Med Virol.</source><year>1990</year><volume>31</volume><fpage>155</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1002/jmv.1890310214</pub-id><pub-id pub-id-type="pmid">2167349</pub-id></element-citation></ref><ref id="B110-molecules-25-05905"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J.-C.</given-names></name></person-group><article-title>Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro</article-title><source>Antivir. Res.</source><year>2003</year><volume>59</volume><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/S0166-3542(03)00030-5</pub-id><pub-id pub-id-type="pmid">12834859</pub-id></element-citation></ref><ref id="B111-molecules-25-05905"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J.-C.</given-names></name><name><surname>Cherng</surname><given-names>J.-M.</given-names></name><name><surname>Hung</surname><given-names>M.-S.</given-names></name><name><surname>Baltina</surname><given-names>L.A.</given-names></name><name><surname>Baltina</surname><given-names>L.</given-names></name><name><surname>Kondratenko</surname><given-names>R.</given-names></name></person-group><article-title>Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: Structure&#x02013;activity relationships</article-title><source>Antivir. Res.</source><year>2008</year><volume>79</volume><fpage>6</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2008.01.160</pub-id><?supplied-pmid 18423902?><pub-id pub-id-type="pmid">18423902</pub-id></element-citation></ref><ref id="B112-molecules-25-05905"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>Y.</given-names></name><name><surname>Matsuura</surname><given-names>T.</given-names></name><name><surname>Aoyagi</surname><given-names>H.</given-names></name><name><surname>Matsuda</surname><given-names>M.</given-names></name><name><surname>Hmwe</surname><given-names>S.S.</given-names></name><name><surname>Date</surname><given-names>T.</given-names></name><name><surname>Watanabe</surname><given-names>N.</given-names></name><name><surname>Watashi</surname><given-names>K.</given-names></name><name><surname>Suzuki</surname><given-names>R.</given-names></name><name><surname>Ichinose</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e68992</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0068992</pub-id><?supplied-pmid 23874843?><pub-id pub-id-type="pmid">23874843</pub-id></element-citation></ref><ref id="B113-molecules-25-05905"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaelis</surname><given-names>M.</given-names></name><name><surname>Geiler</surname><given-names>J.</given-names></name><name><surname>Naczk</surname><given-names>P.</given-names></name><name><surname>Sithisarn</surname><given-names>P.</given-names></name><name><surname>Ogbomo</surname><given-names>H.</given-names></name><name><surname>Altenbrandt</surname><given-names>B.</given-names></name><name><surname>Leutz</surname><given-names>A.</given-names></name><name><surname>Doerr</surname><given-names>H.W.</given-names></name><name><surname>Cinatl</surname><given-names>J.</given-names></name><name><surname>Cinatl</surname><given-names>J.</given-names></name></person-group><article-title>Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages</article-title><source>Med Microbiol. Immunol.</source><year>2010</year><volume>199</volume><fpage>291</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1007/s00430-010-0155-0</pub-id><?supplied-pmid 20386921?><pub-id pub-id-type="pmid">20386921</pub-id></element-citation></ref><ref id="B114-molecules-25-05905"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaelis</surname><given-names>M.</given-names></name><name><surname>Geiler</surname><given-names>J.</given-names></name><name><surname>Naczk</surname><given-names>P.</given-names></name><name><surname>Sithisarn</surname><given-names>P.</given-names></name><name><surname>Leutz</surname><given-names>A.</given-names></name><name><surname>Doerr</surname><given-names>H.W.</given-names></name><name><surname>Cinatl</surname><given-names>J.</given-names></name></person-group><article-title>Glycyrrhizin Exerts Antioxidative Effects in H5N1 Influenza A Virus-Infected Cells and Inhibits Virus Replication and Pro-Inflammatory Gene Expression</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><elocation-id>e19705</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0019705</pub-id><pub-id pub-id-type="pmid">21611183</pub-id></element-citation></ref><ref id="B115-molecules-25-05905"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai-Sugino</surname><given-names>K.</given-names></name><name><surname>Uematsu</surname><given-names>J.</given-names></name><name><surname>Kamada</surname><given-names>M.</given-names></name><name><surname>Taniguchi</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>S.</given-names></name><name><surname>Yoshimi</surname><given-names>Y.</given-names></name><name><surname>Kihira</surname><given-names>S.</given-names></name><name><surname>Yamamoto</surname><given-names>H.</given-names></name><name><surname>Kawano</surname><given-names>M.</given-names></name><name><surname>Tsurudome</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Glycyrrhizin inhibits human parainfluenza virus type 2 replication by the inhibition of genome RNA, mRNA and protein syntheses</article-title><source>Drug Discov. Ther.</source><year>2017</year><volume>11</volume><fpage>246</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.5582/ddt.2017.01048</pub-id><pub-id pub-id-type="pmid">29070744</pub-id></element-citation></ref><ref id="B116-molecules-25-05905"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolkerstorfer</surname><given-names>A.</given-names></name><name><surname>Kurz</surname><given-names>H.</given-names></name><name><surname>Bachhofner</surname><given-names>N.</given-names></name><name><surname>Szolar</surname><given-names>O.H.</given-names></name></person-group><article-title>Glycyrrhizin inhibits influenza A virus uptake into the cell</article-title><source>Antivir. Res.</source><year>2009</year><volume>83</volume><fpage>171</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2009.04.012</pub-id><pub-id pub-id-type="pmid">19416738</pub-id></element-citation></ref><ref id="B117-molecules-25-05905"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Hu</surname><given-names>C.</given-names></name><name><surname>Hood</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Kan</surname><given-names>J.</given-names></name><name><surname>Du</surname><given-names>J.</given-names></name></person-group><article-title>A Novel Combination of Vitamin C, Curcumin and Glycyrrhizic Acid Potentially Regulates Immune and Inflammatory Response Associated with Coronavirus Infections: A Perspective from System Biology Analysis</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>1193</elocation-id><pub-id pub-id-type="doi">10.3390/nu12041193</pub-id></element-citation></ref><ref id="B118-molecules-25-05905"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name></person-group><article-title>Pharmacological perspective: Glycyrrhizin may be an efficacious therapeutic agent for COVID-19</article-title><source>Int. J. Antimicrob. Agents</source><year>2020</year><volume>55</volume><fpage>105995</fpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105995</pub-id><pub-id pub-id-type="pmid">32335281</pub-id></element-citation></ref><ref id="B119-molecules-25-05905"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>J.R.</given-names></name><name><surname>Tripathi</surname><given-names>P.</given-names></name><name><surname>Sharma</surname><given-names>V.</given-names></name><name><surname>Chauhan</surname><given-names>N.S.</given-names></name><name><surname>Dixit</surname><given-names>V.K.</given-names></name></person-group><article-title>Phyllanthus amarus: Ethnomedicinal uses, phytochemistry and pharmacology: A review</article-title><source>J. Ethnopharmacol.</source><year>2011</year><volume>138</volume><fpage>286</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.09.040</pub-id><pub-id pub-id-type="pmid">21982793</pub-id></element-citation></ref><ref id="B120-molecules-25-05905"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanh</surname><given-names>N.D.</given-names></name><name><surname>Sinchaipanid</surname><given-names>N.</given-names></name><name><surname>Mitrevej</surname><given-names>A.</given-names></name></person-group><article-title>Physicochemical characterization of phyllanthin from Phyllanthus amarus Schum. et Thonn</article-title><source>Drug Dev. Ind. Pharm.</source><year>2013</year><volume>40</volume><fpage>793</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.3109/03639045.2013.788010</pub-id><pub-id pub-id-type="pmid">23594304</pub-id></element-citation></ref><ref id="B121-molecules-25-05905"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naaz</surname><given-names>F.</given-names></name><name><surname>Javed</surname><given-names>S.</given-names></name><name><surname>Abdin</surname><given-names>M.</given-names></name></person-group><article-title>Hepatoprotective effect of ethanolic extract of Phyllanthus amarus Schum. et Thonn. on aflatoxin B1-induced liver damage in mice</article-title><source>J. Ethnopharmacol.</source><year>2007</year><volume>113</volume><fpage>503</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2007.07.017</pub-id><?supplied-pmid 17720339?><pub-id pub-id-type="pmid">17720339</pub-id></element-citation></ref><ref id="B122-molecules-25-05905"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venkateswaran</surname><given-names>P.S.</given-names></name><name><surname>Millman</surname><given-names>I.</given-names></name><name><surname>Blumberg</surname><given-names>B.S.</given-names></name></person-group><article-title>Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: In vitro and in vivo studies</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1987</year><volume>84</volume><fpage>274</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1073/pnas.84.1.274</pub-id><?supplied-pmid 3467354?><pub-id pub-id-type="pmid">3467354</pub-id></element-citation></ref><ref id="B123-molecules-25-05905"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agyare</surname><given-names>C.</given-names></name><name><surname>Lechtenberg</surname><given-names>M.</given-names></name><name><surname>Deters</surname><given-names>A.</given-names></name><name><surname>Petereit</surname><given-names>F.</given-names></name><name><surname>Hensel</surname><given-names>A.</given-names></name></person-group><article-title>Ellagitannins from Phyllanthus muellerianus (Kuntze) Exell.: Geraniin and furosin stimulate cellular activity, differentiation and collagen synthesis of human skin keratinocytes and dermal fibroblasts</article-title><source>Phytomedicine</source><year>2011</year><volume>18</volume><fpage>617</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2010.08.020</pub-id><?supplied-pmid 21036574?><pub-id pub-id-type="pmid">21036574</pub-id></element-citation></ref><ref id="B124-molecules-25-05905"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cesari</surname><given-names>I.</given-names></name><name><surname>Grisoli</surname><given-names>P.</given-names></name><name><surname>Paolillo</surname><given-names>M.</given-names></name><name><surname>Milanese</surname><given-names>C.</given-names></name><name><surname>Massolini</surname><given-names>G.</given-names></name><name><surname>Brusotti</surname><given-names>G.</given-names></name></person-group><article-title>Isolation and characterization of the alkaloid Nitidine responsible for the traditional use of Phyllanthus muellerianus (Kuntze) Excell stem bark against bacterial infections</article-title><source>J. Pharm. Biomed. Anal.</source><year>2015</year><volume>105</volume><fpage>115</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2014.11.051</pub-id><?supplied-pmid 25546028?><pub-id pub-id-type="pmid">25546028</pub-id></element-citation></ref><ref id="B125-molecules-25-05905"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajiboye</surname><given-names>T.O.</given-names></name><name><surname>Ahmad</surname><given-names>F.M.</given-names></name><name><surname>Daisi</surname><given-names>A.O.</given-names></name><name><surname>Yahaya</surname><given-names>A.A.</given-names></name><name><surname>Ibitoye</surname><given-names>O.B.</given-names></name><name><surname>Muritala</surname><given-names>H.F.</given-names></name><name><surname>Sunmonu</surname><given-names>T.O.</given-names></name></person-group><article-title>Hepatoprotective potential of Phyllanthus muellarianus leaf extract: Studies on hepatic, oxidative stress and inflammatory biomarkers</article-title><source>Pharm. Biol.</source><year>2017</year><volume>55</volume><fpage>1662</fpage><lpage>1670</lpage><pub-id pub-id-type="doi">10.1080/13880209.2017.1317819</pub-id><?supplied-pmid 28447517?><pub-id pub-id-type="pmid">28447517</pub-id></element-citation></ref><ref id="B126-molecules-25-05905"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasool</surname><given-names>M.</given-names></name><name><surname>Sabina</surname><given-names>E.P.</given-names></name><name><surname>Ramya</surname><given-names>S.R.</given-names></name><name><surname>Preety</surname><given-names>P.</given-names></name><name><surname>Patel</surname><given-names>S.</given-names></name><name><surname>Mandal</surname><given-names>N.</given-names></name><name><surname>Mishra</surname><given-names>P.P.</given-names></name><name><surname>Samuel</surname><given-names>J.</given-names></name></person-group><article-title>Hepatoprotective and antioxidant effects of gallic acid in paracetamol-induced liver damage in mice</article-title><source>J. Pharm. Pharmacol.</source><year>2010</year><volume>62</volume><fpage>638</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1211/jpp.62.05.0012</pub-id><pub-id pub-id-type="pmid">20609067</pub-id></element-citation></ref><ref id="B127-molecules-25-05905"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widodo</surname><given-names>N.</given-names></name><name><surname>Kaur</surname><given-names>K.</given-names></name><name><surname>Shrestha</surname><given-names>B.G.</given-names></name><name><surname>Takagi</surname><given-names>Y.</given-names></name><name><surname>Ishii</surname><given-names>T.</given-names></name><name><surname>Wadhwa</surname><given-names>R.</given-names></name><name><surname>Kaul</surname><given-names>S.C.</given-names></name></person-group><article-title>Selective Killing of Cancer Cells by Leaf Extract of Ashwagandha: Identification of a Tumor-Inhibitory Factor and the First Molecular Insights to Its Effect</article-title><source>Clin. Cancer Res.</source><year>2007</year><volume>13</volume><fpage>2298</fpage><lpage>2306</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-06-0948</pub-id><pub-id pub-id-type="pmid">17404115</pub-id></element-citation></ref><ref id="B128-molecules-25-05905"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elberry</surname><given-names>A.A.</given-names></name><name><surname>Harraz</surname><given-names>F.M.</given-names></name><name><surname>Ghareib</surname><given-names>S.A.</given-names></name><name><surname>Nagy</surname><given-names>A.A.</given-names></name><name><surname>Gabr</surname><given-names>S.A.</given-names></name><name><surname>Suliaman</surname><given-names>M.I.</given-names></name><name><surname>Abdel-Sattar</surname><given-names>E.</given-names></name></person-group><article-title>Antihepatotoxic Effect of Marrubium Vulgare and Withania Somnifera Extracts on Carbon Tetrachloride-Induced Hepatotoxicity in Rats</article-title><source>J. Basic Clin. Pharm.</source><year>2010</year><volume>1</volume><fpage>247</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">24825994</pub-id></element-citation></ref><ref id="B129-molecules-25-05905"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mofed</surname><given-names>D.</given-names></name><name><surname>Ahmed</surname><given-names>W.</given-names></name><name><surname>Zekri</surname><given-names>A.-R.</given-names></name><name><surname>Said</surname><given-names>O.</given-names></name><name><surname>Rahouma</surname><given-names>M.</given-names></name><name><surname>Faraag</surname><given-names>A.H.I.</given-names></name></person-group><article-title>The Antiviral Efficacy of Withania somnifera (Ashwagandha) against Hepatitis C Virus Activity: In Vitro and in Silico Study</article-title><source>Adv. Microbiol.</source><year>2020</year><volume>10</volume><fpage>463</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.4236/aim.2020.109035</pub-id></element-citation></ref><ref id="B130-molecules-25-05905"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munagala</surname><given-names>R.</given-names></name><name><surname>Kausar</surname><given-names>H.</given-names></name><name><surname>Munjal</surname><given-names>C.</given-names></name><name><surname>Gupta</surname><given-names>R.</given-names></name></person-group><article-title>Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells</article-title><source>Carcinogenesis</source><year>2011</year><volume>32</volume><fpage>1697</fpage><lpage>1705</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgr192</pub-id><pub-id pub-id-type="pmid">21859835</pub-id></element-citation></ref><ref id="B131-molecules-25-05905"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pant</surname><given-names>M.</given-names></name><name><surname>Ambwani</surname><given-names>T.</given-names></name><name><surname>Umapathi</surname><given-names>V.</given-names></name></person-group><article-title>Antiviral Activity of Ashwagandha Extract on Infectious Bursal Disease Virus Replication</article-title><source>Indian J. Sci. Technol.</source><year>2012</year><volume>5</volume><fpage>2</fpage><pub-id pub-id-type="doi">10.17485/ijst/2012/v5i5.20</pub-id></element-citation></ref><ref id="B132-molecules-25-05905"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Dhanjal</surname><given-names>J.K.</given-names></name><name><surname>Bhargava</surname><given-names>P.</given-names></name><name><surname>Kaul</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Kaul</surname><given-names>S.C.</given-names></name><name><surname>Wadhwa</surname><given-names>R.</given-names></name><name><surname>Sundar</surname><given-names>D.</given-names></name></person-group><article-title>Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells</article-title><source>J. Biomol. Struct Dyn</source><year>2020</year><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1775704</pub-id><?supplied-pmid 32469279?><pub-id pub-id-type="pmid">32469279</pub-id></element-citation></ref><ref id="B133-molecules-25-05905"><label>133.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Menon</surname><given-names>V.P.</given-names></name><name><surname>Sudheer</surname><given-names>A.R.</given-names></name></person-group><article-title>Antioxidant and anti-inflammatory properties of curcumin</article-title><source>Advances in Experimental Medicine and Biology</source><person-group person-group-type="editor"><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name><name><surname>Surh</surname><given-names>Y.J.</given-names></name><name><surname>Shishodia</surname><given-names>S.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>Boston, MA, USA</publisher-loc><year>2007</year><volume>Volume 595</volume><fpage>105</fpage><lpage>125</lpage></element-citation></ref><ref id="B134-molecules-25-05905"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhasmana</surname><given-names>A.</given-names></name><name><surname>Kashyap</surname><given-names>V.K.</given-names></name><name><surname>Dhasmana</surname><given-names>S.</given-names></name><name><surname>Kotnala</surname><given-names>S.</given-names></name><name><surname>Haque</surname><given-names>S.</given-names></name><name><surname>Ashraf</surname><given-names>G.M.</given-names></name><name><surname>Jaggi</surname><given-names>M.</given-names></name><name><surname>Yallapu</surname><given-names>M.M.</given-names></name><name><surname>Chauhan</surname><given-names>S.C.</given-names></name></person-group><article-title>Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multi Layered High Throughput Virtual Screening Approach</article-title><source>Curr. Pharm. Des.</source><fpage>2020</fpage><pub-id pub-id-type="doi">10.2174/1381612826999200820162937</pub-id><?supplied-pmid 32867645?><pub-id pub-id-type="pmid">32867645</pub-id></element-citation></ref><ref id="B135-molecules-25-05905"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhasmana</surname><given-names>A.</given-names></name><name><surname>Uniyal</surname><given-names>S.</given-names></name><name name-style="given-only"><given-names>Anukriti</given-names></name><name><surname>Kashyap</surname><given-names>V.K.</given-names></name><name><surname>Somvanshi</surname><given-names>P.</given-names></name><name><surname>Gupta</surname><given-names>M.</given-names></name><name><surname>Bhardwaj</surname><given-names>U.</given-names></name><name><surname>Jaggi</surname><given-names>M.</given-names></name><name><surname>Yallapu</surname><given-names>M.M.</given-names></name><name><surname>Haque</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Topological and system-level protein interaction network (PIN) analyses to deduce molecular mechanism of curcumin</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1038/s41598-020-69011-0</pub-id><?supplied-pmid 32694520?><pub-id pub-id-type="pmid">31913322</pub-id></element-citation></ref><ref id="B136-molecules-25-05905"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>C.V.</given-names></name></person-group><article-title>REGULATION OF COX AND LOX BY CURCUMIN</article-title><source>Results Probl. Cell Differ.</source><year>2007</year><volume>595</volume><fpage>213</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1007/978-0-387-46401-5_9</pub-id></element-citation></ref><ref id="B137-molecules-25-05905"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y.S.</given-names></name><name><surname>Young</surname><given-names>M.R.</given-names></name><name><surname>Bobe</surname><given-names>G.</given-names></name><name><surname>Colburn</surname><given-names>N.H.</given-names></name><name><surname>Milner</surname><given-names>J.A.</given-names></name></person-group><article-title>Bioactive food components, inflammatory targets, and cancer prevention</article-title><source>Cancer Prev. Res.</source><year>2009</year><volume>2</volume><fpage>200</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-08-0141</pub-id><?supplied-pmid 19258539?><pub-id pub-id-type="pmid">19258539</pub-id></element-citation></ref><ref id="B138-molecules-25-05905"><label>138.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Surh</surname><given-names>Y.J.</given-names></name><name><surname>Chun</surname><given-names>K.S.</given-names></name></person-group><article-title>Cancer chemopreventive effects of curcumin</article-title><source>The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease</source><publisher-name>Springer</publisher-name><publisher-loc>Boston, MA, USA</publisher-loc><year>2007</year><fpage>149</fpage><lpage>172</lpage></element-citation></ref><ref id="B139-molecules-25-05905"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruck</surname><given-names>R.</given-names></name><name><surname>Ashkenazi</surname><given-names>M.</given-names></name><name><surname>Weiss</surname><given-names>S.</given-names></name><name><surname>Goldiner</surname><given-names>I.</given-names></name><name><surname>Shapiro</surname><given-names>H.</given-names></name><name><surname>Aeed</surname><given-names>H.</given-names></name><name><surname>Genina</surname><given-names>O.</given-names></name><name><surname>Helpern</surname><given-names>Z.</given-names></name><name><surname>Pines</surname><given-names>M.</given-names></name></person-group><article-title>Prevention of liver cirrhosis in rats by curcumin</article-title><source>Liver Int</source><year>2007</year><volume>27</volume><fpage>373</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1111/j.1478-3231.2007.01453.x</pub-id><pub-id pub-id-type="pmid">17355460</pub-id></element-citation></ref><ref id="B140-molecules-25-05905"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Sarmah</surname><given-names>S.</given-names></name><name><surname>Lyndem</surname><given-names>S.</given-names></name><name><surname>Singha Roy</surname><given-names>A.</given-names></name></person-group><article-title>An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study</article-title><source>J. Biomol. Struct Dyn.</source><year>2020</year><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1763201</pub-id></element-citation></ref><ref id="B141-molecules-25-05905"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Praditya</surname><given-names>D.</given-names></name><name><surname>Kirchhoff</surname><given-names>L.</given-names></name><name><surname>Br&#x000fc;ning</surname><given-names>J.</given-names></name><name><surname>Rachmawati</surname><given-names>H.</given-names></name><name><surname>Steinmann</surname><given-names>J.</given-names></name><name><surname>Steinmann</surname><given-names>E.</given-names></name></person-group><article-title>Anti-infective Properties of the Golden Spice Curcumin</article-title><source>Front. Microbiol.</source><year>2019</year><volume>10</volume><fpage>912</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.00912</pub-id><pub-id pub-id-type="pmid">31130924</pub-id></element-citation></ref><ref id="B142-molecules-25-05905"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panico</surname><given-names>A.</given-names></name><name><surname>Cardile</surname><given-names>V.</given-names></name><name><surname>Garufi</surname><given-names>F.</given-names></name><name><surname>Puglia</surname><given-names>C.</given-names></name><name><surname>Bonina</surname><given-names>F.</given-names></name><name><surname>Ronsisvalle</surname><given-names>G.</given-names></name></person-group><article-title>Protective effect of Capparis spinosa on chondrocytes</article-title><source>Life Sci.</source><year>2005</year><volume>77</volume><fpage>2479</fpage><lpage>2488</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2004.12.051</pub-id><pub-id pub-id-type="pmid">15946691</pub-id></element-citation></ref><ref id="B143-molecules-25-05905"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>B.</given-names></name><name><surname>Alam</surname><given-names>T.</given-names></name><name><surname>Varshney</surname><given-names>M.</given-names></name><name><surname>Alam Khan</surname><given-names>S.</given-names></name></person-group><article-title>Hepatoprotective activity of two plants belonging to the Apiaceae and the Euphorbiaceae family</article-title><source>J. Ethnopharmacol.</source><year>2002</year><volume>79</volume><fpage>313</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(01)00392-0</pub-id><pub-id pub-id-type="pmid">11849834</pub-id></element-citation></ref><ref id="B144-molecules-25-05905"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huseini</surname><given-names>H.F.</given-names></name><name><surname>Alavian</surname><given-names>S.</given-names></name><name><surname>Heshmat</surname><given-names>R.</given-names></name><name><surname>Heydari</surname><given-names>M.</given-names></name><name><surname>Abolmaali</surname><given-names>K.</given-names></name></person-group><article-title>The efficacy of Liv-52 on liver cirrhotic patients: A randomized, double-blind, placebo-controlled first approach</article-title><source>Phytomedicine</source><year>2005</year><volume>12</volume><fpage>619</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2004.10.003</pub-id><?supplied-pmid 16194047?><pub-id pub-id-type="pmid">16194047</pub-id></element-citation></ref><ref id="B145-molecules-25-05905"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gadgoli</surname><given-names>C.</given-names></name><name><surname>Mishra</surname><given-names>S.H.</given-names></name></person-group><article-title>Antihepatotoxic activity of p-methoxy benzoic acid from Capparis spinosa</article-title><source>J. Ethnopharmacol.</source><year>1999</year><volume>66</volume><fpage>187</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(98)00229-3</pub-id><pub-id pub-id-type="pmid">10433476</pub-id></element-citation></ref><ref id="B146-molecules-25-05905"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>J.</given-names></name><name><surname>Mujahid</surname><given-names>M.</given-names></name><name><surname>Badr</surname><given-names>B.</given-names></name><name name-style="given-only"><given-names>Rahman</given-names></name><name><surname>Akhtar</surname><given-names>J.</given-names></name><name><surname>Khalid</surname><given-names>M.</given-names></name><name><surname>Jahan</surname><given-names>Y.</given-names></name><name><surname>Basit</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name><name><surname>Shawwal</surname><given-names>M.</given-names></name><etal/></person-group><article-title>An insight of pharmacognostic study and phytopharmacology of Aquilaria agallocha</article-title><source>J. Appl. Pharm. Sci.</source><year>2015</year><volume>5</volume><fpage>173</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.7324/JAPS.2015.50827</pub-id></element-citation></ref><ref id="B147-molecules-25-05905"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>J.</given-names></name><name name-style="given-only"><given-names>Mujahid</given-names></name><name name-style="given-only"><given-names>Badruddeen</given-names></name><name><surname>Jahan</surname><given-names>Y.</given-names></name><name><surname>Bagga</surname><given-names>P.</given-names></name><name><surname>Rahman</surname><given-names>A.</given-names></name></person-group><article-title>Hepatoprotective potential of ethanolic extract of Aquilaria agallocha leaves against paracetamol induced hepatotoxicity in SD rats</article-title><source>J. Tradit. Complement. Med.</source><year>2017</year><volume>7</volume><fpage>9</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.jtcme.2015.12.006</pub-id><?supplied-pmid 28053882?><pub-id pub-id-type="pmid">28053882</pub-id></element-citation></ref><ref id="B148-molecules-25-05905"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>H.</given-names></name><name><surname>Kabir</surname><given-names>N.</given-names></name><name><surname>Muhammad</surname><given-names>A.</given-names></name><name><surname>Shah</surname><given-names>M.R.</given-names></name><name><surname>Musharraf</surname><given-names>S.G.</given-names></name><name><surname>Iqbal</surname><given-names>N.</given-names></name><name><surname>Nadeem</surname><given-names>S.</given-names></name></person-group><article-title>Hautriwaic acid as one of the hepatoprotective constituent of Dodonaea viscosa</article-title><source>Phytomedicine</source><year>2014</year><volume>21</volume><fpage>131</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2013.08.019</pub-id><pub-id pub-id-type="pmid">24075215</pub-id></element-citation></ref><ref id="B149-molecules-25-05905"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahid</surname><given-names>A.</given-names></name><name><surname>Hamed</surname><given-names>A.N.</given-names></name><name><surname>Eltahir</surname><given-names>H.M.</given-names></name><name><surname>Abouzied</surname><given-names>M.M.</given-names></name></person-group><article-title>Hepatoprotective activity of ethanolic extract of Salix subserrata against CCl4-induced chronic hepatotoxicity in rats</article-title><source>BMC Complement. Altern. Med.</source><year>2016</year><volume>16</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1186/s12906-016-1238-2</pub-id><pub-id pub-id-type="pmid">26729470</pub-id></element-citation></ref><ref id="B150-molecules-25-05905"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domitrovi&#x00107;</surname><given-names>R.</given-names></name><name><surname>Poto&#x0010d;njak</surname><given-names>I.</given-names></name></person-group><article-title>A comprehensive overview of hepatoprotective natural compounds: Mechanism of action and clinical perspectives</article-title><source>Arch. Toxicol.</source><year>2016</year><volume>90</volume><fpage>39</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1007/s00204-015-1580-z</pub-id><pub-id pub-id-type="pmid">26377694</pub-id></element-citation></ref><ref id="B151-molecules-25-05905"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>G.</given-names></name><name><surname>Khosa</surname><given-names>R.L.</given-names></name><name><surname>Singh</surname><given-names>P.</given-names></name><name><surname>Jha</surname><given-names>K.K.</given-names></name></person-group><article-title>Hepatoprotective potential of ethanolic extract of Pandanus odoratissimus root against paracetamol-induced hepatotoxicity in rats</article-title><source>J. Pharm. Bioallied Sci.</source><year>2015</year><volume>7</volume><fpage>45</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.4103/0975-7406.148776</pub-id><pub-id pub-id-type="pmid">25709336</pub-id></element-citation></ref><ref id="B152-molecules-25-05905"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname><given-names>S.</given-names></name><name><surname>Bhattacharjee</surname><given-names>A.</given-names></name><name><surname>Mukherjee</surname><given-names>S.</given-names></name><name><surname>Bhattacharya</surname><given-names>K.</given-names></name><name><surname>Khowala</surname><given-names>S.</given-names></name></person-group><article-title>Antioxidant and Hepatoprotective Activity of Ethanolic Extract of Alocasia indica Tuber</article-title><source>Am. J. Phytomedicine Clin. Ther.</source><year>2014</year><volume>2</volume><fpage>191</fpage><lpage>208</lpage></element-citation></ref><ref id="B153-molecules-25-05905"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez-Ponce</surname><given-names>H.A.</given-names></name><name><surname>Mart&#x000ed;nez-Salda&#x000f1;a</surname><given-names>M.C.</given-names></name><name><surname>Rinc&#x000f3;n-S&#x000e1;nchez</surname><given-names>A.R.</given-names></name><name><surname>Sumaya-Mart&#x000ed;nez</surname><given-names>T.</given-names></name><name><surname>Buist-Homan</surname><given-names>M.</given-names></name><name><surname>Faber</surname><given-names>K.N.</given-names></name><name><surname>Moshage</surname><given-names>H.</given-names></name><name><surname>Jaramillo-Ju&#x000e1;rez</surname><given-names>F.</given-names></name></person-group><article-title>Hepatoprotective Effect of Opuntia robusta and Opuntia streptacantha Fruits against Acetaminophen-Induced Acute Liver Damage</article-title><source>Nutrients</source><year>2016</year><volume>8</volume><elocation-id>607</elocation-id><pub-id pub-id-type="doi">10.3390/nu8100607</pub-id><?supplied-pmid 27782042?><pub-id pub-id-type="pmid">27782042</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-25-05905-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Global COVID-19 pandemic. (<bold>A</bold>); SARS-CoV-2 structure (<bold>B</bold>); Schematic representation of putative worldwide distribution of total cases, total deaths, and the active cases of COVID-19. (<bold>C</bold>); The number of total COVID-19 cases and deaths associated to COVID-19 was derived from Worldometer. Information obtained from <uri xlink:href="https://www.worldometers.info/coronavirus/">https://www.worldometers.info/coronavirus/</uri> on 12 December 2020.</p></caption><graphic xlink:href="molecules-25-05905-g001"/></fig><fig id="molecules-25-05905-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Schematic diagram showing the potential mechanisms of liver injury and abnormality in liver. (<bold>A</bold>); COVID-19 infection through the respiratory tract. (<bold>B</bold>); SARS-CoV-2 binds <italic>via</italic> its spike proteins to target cells receptor angiotensin-converting enzyme II (ACE2). (<bold>C</bold>); Liver function impairment with a mild-to-moderate increase of liver function enzymes level in the bloodstream.</p></caption><graphic xlink:href="molecules-25-05905-g002"/></fig><fig id="molecules-25-05905-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Schematic representations show multiple factors are responsible for COVID-19 associated liver toxicity/injury. Factors include cytokine storm, direct viral replication, antipyretics induced toxicity, hypoxia, antiviral induced toxicity, and pre-existing liver disease.</p></caption><graphic xlink:href="molecules-25-05905-g003"/></fig><fig id="molecules-25-05905-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Various medicinal plants possessing potential hepatoprotective activities.</p></caption><graphic xlink:href="molecules-25-05905-g004"/></fig></floats-group></article>